Programm A4 - Österreichische Gesellschaft für Allergologie und ...

Österreichische Gesellschaft für Allergologie und Immunologie
&
Deutsche Gesellschaft für Immunologie
JOINT ANNUAL MEETING
OF IMMUNOLOGY
OF THE
AUSTRIAN AND GERMAN SOCIETIES
Lecture Centre of the Vienna General Hospital
Vienna, Austria
Wednesday, September 3 – Saturday, September 6, 2008
Final Programme
www.medacad.org/oegai2008

ALLERGIE LAUF
Sonntag, 7. September 2008
Schlosspark Schönbrunn
Hiermit laden wir Sie ganz herzlich dazu ein, im Anschluss an den Kongress
„Joint Annual Meeting of Immunology, Wien, 3.-6. September 2008“, am
ALLERGIE LAUF am Sonntag, 7. September 2008
im SCHLOSSPARK SCHÖNBRUNN,
einer der schönsten Parkanlagen Wiens, teilzunehmen.
Nach dem Startschuss von Nobelpreisträger Peter Doherty geht es durch den Schlosspark Schönbrunn,
durch Alleen mit barocker Gartenbaukunst, und vorbei am Schloss Schönbrunn, einem der bedeutendsten
Kulturdenkmäler Österreichs, einst bewohnt von Kaiserin Sissi und heute ein beliebtes Ausflugsziel vieler
Wiener und Wienbesucher.
Sie können unter verschiedenen Distanzen wählen und auch im Team laufen. Das Tempo bleibt Ihnen
überlassen: gemütlich oder mit sportlichem Ehrgeiz, dazu wird es eine exakte elektronische Zeitmessung
geben. Ob Kongressteilnehmer oder nicht - es sind alle eingeladen, mit zu laufen.
Im Anschluss an den Lauf folgen als Krönung des Tages und als Belohnung für Ihren sportlichen Einsatz
und das tüchtige anfeuern Ihrer Fans, die After Running Party, die Siegerehrung, eine Tombola, ein
Buffet reich an köstlichen typisch österreichischen Gerichten, und eine Musikshow. Es unterhalten
Sie Harry Sonnek und der legendäre Dave Dee, der mit seinen besten Songs aus den 60ern aus London
zu uns kommen wird und für die richtige Partystimmung sorgen wird. Zur After Running Party sind alle
Läufer und deren Begleiter ganz herzlich eingeladen.
Bitte nutzen Sie die Möglichkeit der Online-Anmeldung auf www.medacad.org/oegai2008 unter „Allergy
Run“ sobald als möglich, damit Sie sich Ihr, in der Gebühr inkludiertes, Erinnerungs- T-Shirt in der
richtigen Größe sichern.
Auf der Homepage finden Sie auch alle mit dem Lauf verbundenen Informationen, sowie den vorläufigen
Streckenplan.
Wir freuen uns auf zahlreiche Anmeldungen!
www.bundesgaerten.at

Österreichische Gesellschaft für Allergologie und Immunologie
&
Deutsche Gesellschaft für Immunologie
JOINT ANNUAL MEETING
OF IMMUNOLOGY
OF THE
AUSTRIAN AND GERMAN SOCIETIES
Lecture Centre of the Vienna General Hospital
Vienna, Austria
Wednesday, September 3 – Saturday, September 6, 2008
Final Programme
www.medacad.org/oegai2008

Table of Contents
General
Patronage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Welcome Addresses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Committees – Board – Organisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Programme at a Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Scientific Programme
- Wednesday, September 3, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
- Thursday, September 4, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
- Friday, September 5, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
- Saturday, September 6, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Poster Viewing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Business Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Satellite Lunch Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27
Information on Posters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Information for Speakers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Information
Congress Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Registration Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Venue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Social Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
City Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Exhibition
Exhibition – General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
List of Sponsors, Exhibitors and Advertisers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
1

Patronage
Under the Patronage of
Dr. Alfred Gusenbauer
Federal Chancellor of the Federal Republic of Austria
Dr. Johannes Hahn
Federal Minister for Science and Research
Dr. Andrea Kdolsky
Federal Minister for Health, Family and Youth
Mag. Sonja Wehsely
Executive City Councillor for Public Health and Social Affairs
Acknowledgements
The Joint Annual Meeting of Immunology gratefully acknowledges the support of the following
institutions, companies and organisations (list correct as per date of printing):
2

Welcoming Addresses
Unquestionably a high level of health care is the core element of our modern
welfare system as we know it. It is therefore our duty as politicians to secure
the basis for its long-term financial stability. Furthermore, we must create an
institutional and legal framework to guarantee universal and non-discriminatory
access to all forms of treatment. Nobody should be excluded or left
behind. Only under these conditions can health-care professionals fulfil their
essential duty and live up to their oath i.e. helping people.
Public opinion polls show the high satisfaction of Austrians with our national
health care system. But no society can satisfy itself with self appreciation. Many challenges lie
ahead of us. Some are institutional, financial, others are scientific. This congress will help to promote
knowledge and hopefully inspire all working in your field.
On behalf of the Austrian government it is my pleasure to welcome you here in Austria and in
particular at this “Joint Annual Meeting of Immunology”.
Dr. Alfred Gusenbauer
Federal Chancellor of the Federal Republic of Austria
More than 1000 participants at the „Joint Annual Meeting of lmmunology"
give invigorating proof of the importance and international reputation of the
Societies of Allergology and Immunology in Austria and Germany on the one
hand and the Vienna Medical Academy in the fields of education/research as
well as conference and association management – an organisation dedicated
to serving the needs of the medical non-profit community - on the other. As
minister of Science and Research it is good news for me that international
experts are discussing such pressing topics as vaccination, infection and
allergy just now in Austria. That means new incentives for the Scientific Community
especially in our country and the opportunity to expand international networking. These
issues are of great relevance for nearly all of us and the expectations are very high, if you only think
of tumor immunology for example. May the meeting be a successful one with impressing results
and congratulations on bringing together university professors of international reputation in this
field in Vienna for the first time. In this way the meeting is a great recognition of Vienna as an important
medical research place.
Dr. Johannes Hahn
Federal Minister for Science and Research
3

Welcoming Addresses
Dear colleagues and scientific friends,
It is our great pleasure to welcome you to the Joint Annual Meeting of the Austrian and the German
Societies of Immunology in Vienna.
The annual conferences of our societies allow for an exchange of thoughts and information on cutting
edge developments taking place in the immunological laboratories worldwide. The format of
a joint annual conference allows for an expansion of this exchange into a neighbouring country
and likewise fosters new and/or permits to renew longstanding scientific and social relationships.
With this meeting we are aiming to delineate the latest progress in our field, focusing on matters
arising not only in basic innate and adaptive immunity, but also clinical immunology including
novel therapeutic approaches. The scientific committee has invited outstanding scientists to present
their thinking and to summarize data on their advances in plenary sessions and introductions
to workshops. Within workshops and during the poster sessions, there will be ample opportunity
especially for students and postdoctoral fellows to present their newest research results and thus
a broad array of work which is performed in the realm of the hosting societies and beyond.
We have made all efforts to create a scientific program that meets your expectations. In addition
you shall enjoy Vienna´s ambience and hospitality, the unique culture and spirit which so few
other cities have to offer.
With best wishes for a scientifically exciting and
stimulating meeting and
mit herzlichen Grüßen,
Yours
Stefan Meuer & Josef Smolen
4

Committees – Board – Organisation
Congress Committee
Stefan C.W. Meuer Josef Smolen
Andreas Radbruch Marcus Säemann
Reinhold E. Schmidt
Local Organising Committee
Irmgard Förster Marcus Säemann
Beatrix Grubeck-Loebenstein Reinhold Schmidt
Erika Jensen-Jarolim Josef Smolen
Stefan C.W. Meuer Hannes Stockinger
Winfried Pickl Rudolf Valenta
Andreas Radbruch Gerhard Zlabinger
ÖGAI Executive Committee
Josef Smolen (President) Gernot Achatz (Board Member)
Rudolf Valenta (President Elect) Hans-Peter Brezinsek (Board Member)
Beatrix Grubeck-Loebenstein (Past President) Roswitha Gruber-Sgonc (Board Member)
Marcus Säemann (Secretary General) Erika Jensen-Jarolim (Board Member)
Winfried Pickl (Deputy Secretary) Johannes Stöckl (Board Member)
Tamara Kopp (Secretary Protocol) Martin Thurnher (Board Member)
Barbara Bohle (Treasurer) Othmar Förster (Honorary President)
DGfI Executive Committee
Stefan C.W. Meuer (President) Reinhold Förster (Board Member)
Andreas Radbruch (President Elect) Stefan H. E. Kaufmann (Board Member)
Reinhold E. Schmidt (Past President) Heidrun Moll (Board Member)
Werner Solbach (Secretary General) Yvonne Samstag (Board Member)
Christian Bogdan (Board Member) Burkhart Schraven (Board Member)
Barbara Bröker (Board Member) Hans Dieter Volk (Board Member)
Stefan Ehlers (Board Member)
Irmgard Förster (Board Member)
Hans-Martin Jäck (Board Member)
Conference Organisation, Abstract Management, Sponsoring
Vienna Medical Academy
Ms. Marieke Hodel
Alser Strasse 4, 1090 Vienna, Austria
Phone: +43 1 405 1383-10; Fax: +43 1 407 8274
E-mail: oegai2008@medacad.org
Exhibition Management Hotel Accomodation
Medizinische Ausstellungs- und Mondial Congress & Events
Werbegesellschaft MAW Operngasse 20b
Freyung 6 1040 Vienna
A-1010 Vienna, Austria Phone: +43 1 58804-0
Phone: +43 1 536 630 Fax: +43 1 58804-185
Fax: +43 1 535 60 16
E-mail: maw@media.co.at
Email: oegai2008@mondial-congress.com
Congress Venue
Lecture Centre of the Vienna General Hospital
(Allgemeines Krankenhaus - AKH)
Währinger Gürtel 18-20
1090 Vienna, Austria
5

Programme at a Glance
Wednesday, September 3, 2008
Time Lecture Hall 1
Welcome and Opening
Stefan Meuer, President DGfI
Josef Smolen, President ÖGAI
15.00 –
15.10
Karl Landsteiner (1868-1943) - An Austrian Immuno-Pathologist (G. Schmidt-Wyklicky)
Awarding of the Landsteiner Price of the DGfI to Max Cooper
Awarding of the Landsteiner Medal of the ÖGAI to Ron Germain
Vienna Philharmonic
Keynote Lecture: Nobel Laureate Peter Doherty
Vienna Philharmonic
Opening by Wolfgang Schütz (Rector of the Medical University of Vienna)
15.10 –
15.25
15.25 –
15.45
15.45 –
16.05
16.05 –
16.20
16.20 –
16.50
16.50 –
17.00
17.00 –
17.15
Followed by Welcome Drinks
Thursday, September 4, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
Parallel Symposium 1:
08.15 – Parallel Symposium 1:
Parallel Symposium 1:
Innate Immunity: Antigen-Presenting-
09.30 T-Cell Signaling
Tumor Immunology
Cells
Break & Poster Viewing
Innate Immunity: Antigen-Presenting
Cells
T-Lymphocytes I Autoimmunity I Tumor Immunology Immunomodulation
09.30 –
10.30
10.30 –
12.15
Satellite Lunch Symposium:
B cell: Promising target in autoimmune
diseases (Roche)
T-Lymphocytes II Vaccines & Adjuvants Signal Transduction NK cells Veterinary Immunology
12.15 –
13.45
14.00 –
15.30
15.30 –
Break & Poster Viewing
16.30
16.45 – Parallel Symposium 2:
Parallel Symposium 2:
Parallel Symposium 2:
18.00 Vaccination
In vivo imaging
Immunomodulation
19.00 Welcome Reception at the Vienna City Hall
6
Plenary Session Parallel Symposium Workshops Satellite Lunch Symposium

Programme at a Glance
Friday, September 5, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
08.15 – Parallel Symposium 1:
Parallel Symposium 1:
Parallel Symposium 1:
09.30 Innate Immunity: Regulation
Mucosal Inflammation
Transplantation
09.30 –
Break & Poster Viewing
10.30
10.30 –
Pattern Recognition Receptors &
Allergy I Regulatory Lymphocytes I Alloimmunity & Tolerance
Innate Immunity: Regulation
12.15
Myeloid Cells
12.15 –
Satellite Lunch Symposium:
13.00
Immune modulation with intravenous
13.00 – Drittmittelförderung der DFG: Kriterien immunoglobulin: the established and
13.45 für eine erfolgreiche Antragstellung the advances (Octapharma)
14.00 –
Infection I Allergy II Regulatory Lymphocytes II Mucosal Immunity B-Lymphocytes
15.30
15.30 –
Break & Poster Viewing
16.30
16.45 – Parallel Symposium 2:
Parallel Symposium 2:
Parallel Symposium 2:
18.00 Infection
Adaptive Immunity: Regulation Adaptive Immunity: B-Cells
18.00 –
General Assembly DGfI
19.30
19.30 Departure with buses to the Viennese “Heuriger” Fuhrgassl-Huber
Saturday, September 6, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
08.45 – Parallel Symposium 1:
Parallel Symposium 1:
Parallel Symposium 1:
10.00 Autoimmunity
Inflammation
Allergy
10.00 –
Break
10.30
10.30 –
Cytokines, Chemokines & their
Satellite Lunch Symposium:
Autoimmunity II Infection II Complement System
12.15
receptors
Vom rekombinanten Allergen zu
12.15 –
neuen Allergietherapien (Phadia)
12.45
Break
12.45 –
Break
13.00
13.00 – Klinische Fälle aus der Allergologie:
13.45 Wie hätten Sie entschieden?
14.00 –
Best Poster Awards
14.30
15.00 General Assembly ÖGAI
7
Plenary Session Parallel Symposium Workshops Satellite Lunch Symposium

Scientific Programme – Wednesday, September 3, 2008 8
Time Lecture Hall 1
15.00
-
15.10
15.10
-
15.25
15.25
-
15.45
15.45
-
16.05
16.05
-
16.20
16.20
-
16.50
16.50
-
17.00
17.00
-
17.15
Welcome
Chair: S. Meuer, J. Smolen
Welcoming addresses by
Stefan Meuer, President DGfI
Josef Smolen, President ÖGAI
Karl Landsteiner (1868-1943) - An Austrian Immuno-Pathologist
Gabriela Schmidt-Wyklicky
Awarding of the Landsteiner Price of the DGfI to Max Cooper
Laudatio: Andreas Radbruch
Award Lecture: Max Cooper
Awarding of the Landsteiner Medal of the ÖGAI to Ron Germain
Laudatio: Clemens Scheinecker
Award Lecture: Ron Germain
Rainer Honeck, Concert Master of the The Vienna Philharmonic Orchestra: J.S. Bach
Keynote Lecture:
Nobel laureate Peter Doherty
Rainer Honeck, Concert Master of the Vienna Philharmonic Orchestra: F. Kreisler
Opening by Wolfgang Schütz (Rector of the Medical University of Vienna)
17.15 Welcome Drinks

Scientific Programme – Thursday, September 4, 2008 9
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3
08.15
-
09.30
09.30
-
10.30
Parallel Symposium 1:
T-Cell Signaling
Chair: W. Pickl, D. Kabelitz
Molecular determinants of Inside-out
signaling in T-cells
B. Schraven
From T cell activation signals to signaling
control of anti-cancer immunity
J. Penninger
Deciphering TCR ligand discrimination by
combining experiments, computer
modeling, and predictive simulations
R. Germain
Parallel Symposium 1:
Innate Immunity: Antigen-Presenting-
Cells
Chair: G. Stingl, B. Broeker
DC dependent maintenance of peripheral
regulatory T-cells
S. Beissert
Role of antimicrobial peptides in triggering
autoimmunity
M. Gilliet
TLR-activated dendritic cells as effector
cells of the immune response
G. Stingl
Coffee Break / Poster Viewing / Exhibition
Parallel Symposium 1:
Tumor Immunology
Chair: E. Jensen-Jarolim, G. Riethmüller
Human Self/Tumor Antigens and Tumor
Immunosurveillance
O.J. Finn
The immune response to sporadic cancer
T. Blankenstein
Development of DNA vaccination strategies
for pediatric cancers
H.N. Lode

Scientific Programme – Thursday, September 4, 2008 10
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
10.30
-
12.15
T-Lymphocytes I
Chair: G. Schütz,
H. Wolf
1. Increased Th17 and
decreased CD4+FoxP3+
T regulatory cells in third
trimester pregnancies
with pre-eclampsia
B. Santner-Nanan,
M. Peek, L. Richarts,
R. Khanam, E. Zhu, B.
Fazekas de St. Groth,
R. K. Nanan
2. Blockade of inducible
costimulator (ICOS) inhibits
accumulation of
polyfunctional
Th1/Th17cCells and prevents
autoimmune arthritis
O. Frey, J. Meisel,
L. Bruns, A. Hutloff,
L. Morawietz, T. Kamradt
3. IRF4 is essential for
IL-21-mediated induction,
amplification and
stabilization of the Th17
phenotype
M. Huber, A. Brüstle,
A. Guralnik, A. Mahiny,
E. von Löw, M. Lohoff
4. Acid sphingomyelinase
is a critical regulator
of cytotoxic granule
secretion by primary T
lymphocytes
J. Herz, J. Pardo,
H. Kashkar,
M. Schramm,
E. Kuzmenkina, E. Bos,
K. Wiegmann,
R. Wallich, P. J. Peters,
S. Herzig, E. Schmelzer,
M. Krönke, M. M. Simon,
O. Utermöhlen
5. Adenosine regulates
CD8 T cell priming by inhibition
of membraneproximal
T cell receptor
signaling
D. Stabenow,
C. Linnemann,
F. A. Schildberg,
A. Schurich,
S. I. Hegenbarth,
L. Diehl, E. Endl,
S. Lacher, C. E. Müller,
J. Frey, L. Simeoni,
L. Simeoni, B. Schraven,
P. A. Knolle
6. pSMAC formation in
human peripheral blood
T-cells requires localization
of the actin-bundling
protein L-plastin to the
immunological synapse
G. Wabnitz, P. Lohneis,
H. Kirchgessner,
Y. Samstag
Autoimmunity I
Chair: H. Strobl,
G. Beilhack
9. The role of B cells in
tissue draining lymphnodes
for the development
of collagen
induced arthritis (CIA)
C. Scheinecker,
A. Rapp, M. Bonelli,
A. Savitskaya,
J. S. Smolen
10. T helper cells only induce
acute inflammation
but B cells are necessary
for the induction of
chronic Antigen-induced
Arthritis
M. Janke, T. Hohnstein,
L. Morawietz,
A. Scheffold
11. Crucial role of CCR4
in the development of
experimental CNS autoimmune
disease by
modulation of Treg cell
compartimentalization
J. Alferink, D. M. Otte,
K. Poppensieker,
Ö. Yilmaz, A. Mildner,
M. Prinz, W. Maier,
A. Zimmer
12. Antigen-specific
TGF -induced Treg suppress
Th17-mediated
autoimmune disease
E. N. Huter,
G. H. Stummvoll,
E. M. Shevach
13. The pathogenic role
of HnRNP-A2 in Pristane-induced
arthritis
M. H. Hoffmann, C.
Baumann, B. Meyer,
G. Steiner
14. The autoimmune regulator
Roquin-a cofactor
for miRNA function?
E. Glasmacher,
K. P. Höfig, E. Kremmer,
V. Heissmeyer
Tumor Immunology
Chair: J. Singer,
T. Weichhart
17. Higher avidity of
TCR-gene-modified T
cells by using parts of
the murine constant TCR
regions
D. Sommermeyer,
W. Uckert
18. Reprogramming T
cells to become MHC independent
- electroporation
of RNA encoding
chimeric antigen receptors
N. Schaft, T. Schunder,
C. Krug, S. Reuter,
D. Kosmides, H. Abken,
M. Kershaw,
E. Kämpgen, G. Schuler,
J. Dörrie
19. Memory CD8+ T-cell
mediated tumor rejection
is impaired in NKG2Ddysfunctional
mice
M. C. Banerjea,
D. Sigurdardottir,
B. Pömmerl,
H. Rammensee,
A. Steinle
20. Rejection of established
cancer: Lack of
IFN- , TNF- and Fas-ligand
but not perforin by
effector CD8+ T cells allows
cancer to progress
J. J. Listopad,
G. Willimsky,
B. Silkenstedt,
T. Kammertöns,
T. Blankenstein
21. Defects of the antigen
processing machinery
leading to T cell
resistance of melanoma
cells
M. Keller, F. Ebstein,
A. Paschen, E. Bürger,
D. Schadendorf,
P. M. Kloetzel,
U. Seifert
22. Tumor-specific T
helper cells regulate
tumor dormancy or
progress multistage carcinogenesis
through T
cell cytokines
H. Braumueller,
T. Wieder, N. Bauer,
M. Rocken
Immunomodulation
Chair: K. Loser,
W. Berger
25. Regulation of homing
receptor expression in
CD4 + T cells
B. A. Ratsch, C. Doebis,
S. Jennrich, S. Floess,
A. Hamann, U. Syrbe
26. Regulated release
and functional modulation
of junctional adhesion
molecule A by
disintegrin metalloproteinases
J. Pruessmeyer,
R. Koenen, L. Fraemohs,
O. Soehnlein, C. Weber,
A. Ludwig
27. Ontogeny of Langerhans
cells in prenatal
human skin
C. Schuster, C. Vaculik,
C. Fiala, W. Eppel,
S. Meindl, M. Imhof,
A. Elbe-Bürger
28. Requirement of
CCL17 for progression
of atopic dermatitis and
contact hypersensitivity
in mice
S. Stutte, N. Gerbitzki,
I. Förster
29. Acid sphingomyelinase
is required for efficient
phago-lysosomal
fusion
M. Schramm, U. Karow,
A. Haas, M. Krönke,
O. Utermöhlen
30. Phenotypic and molecular
analysis of an
HLA Class II deficient
patient reveals a homozygous
nonsense
mutation in the CIITA
gene at amino acid position
381
K. G. Schmetterer,
M. G. Seidel,
U. Körmöczi,
K. Schwarz, S. Matthes-
Martin, P. Steinberger,
W. F. Pickl
Innate Immunity: Antigen-Presenting
Cells
Chair: N. Romani,
H. Schild
33. Targeting of
Haemagglutinin antigen
to C-type Lectins on
human Dendritic Cells
elicits different T cell responses
in vitro
G. F. Heidkamp,
F. Nimmerjahn,
A. Piperno, H. Zebroski,
R. M. Steinman,
M. C. Nussenzweig,
D. Dudziak
34. PPARgamma enhances
uptake and
cross-presentation of
soluble antigen in dendritic
cells
S. Hucke, J. Floßdorf,
I. Dani, D. Thimm,
A. Kautz, C. Kurts,
P. Knolle, L. Klotz,
S. Burgdorf
35. Genomic RNA of
human rhinovirus - a
”semi-danger-signal” for
dendritic cells
C. Schrauf,
S. Kirchberger,
O. Majdic, J. Seipelt,
J. Stöckl
36. Antagonism between
GATA-1 and vitamin D3
receptor in myelopoisis
and dendritic cell subset
differentiation
S. Taschner-Mandl,
F. Göbel, M. Kumerz,
J. Jurkin, C. Vaculik,
S. Richter, C.
Bieglmayer,
A. Elbe-Bürger,
H. Strobl
37. Function of hypoxiainducible
factor (HIF)-1
in dendritic cells
T. Köhler,
R. S. Johnson,
H. Weighardt, I. Förster
38. Distinct mechanism
of antigen routing and
cross-presentation in
LSEC
A. K. Schurich,
J. Böttcher, S. Burgdorf,
P. Penzler,
S. Hegenbarth,
D. Stabenow, A. Dolf,
E. Endl, C. Kurts,
P. A. Knolle

Scientific Programme – Thursday, September 4, 2008 (continued) 11
Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
7. The effect of thymectomy
in early childhood
on the naive T cell compartment
in later life
M. Prelog, M. Keller,
R. Geiger, A. Brandstaetter,
R. Würzner,
B. Grubeck-Loebenstein,
L. B. Zimmerhackl
8. Clonal evolution of the
effector T cell repertoire
D. Zehn, M. J. Bevan
Time Lecture Hall 1
12.15
-
13.45
15. OSCAR, a key costimulation
molecule for
osteoclasts, is induced
in patients with rheumatoid
arthritis
S. Herman, G. Krönke,
R. Müller, J. Zwerina,
K. Redlich, G. Schett
16. Imaging immuneneuronal
interactions in
experimental auto -
immune encephalo -
myelitis using intravital
two- photon microscopy
V. Siffrin, J. Herz,
T. Leuenberger,
A. U. Brandt,
H. Radbruch, R. Niesner,
C. Infante-Duarte,
F. Zipp
Satellite Lunch Symposium - Roche
B cell: Promising target in autoimmune diseases
Chair: J. Smolen
The biology of the B cell in autoimmune diseases
A. Radbruch
Clinical experiences with B cell therapies
T. Dörner
Safety: Experiences with Rituximab
H-P. Brezinsek
23. Identification of
tumor antigens using antibodies
induced by dendritic
cell (DC) based
vaccines
J. Leitner, A. Stift,
J. Friedl, R. Pfranger,
P. Steinberger,
K. Pfistershammer
24. Serological relationship
between cutaneous
human papillomavirus
types 5, 8 and 92
A. Handisurya,
C. Schellenbacher,
R. Gambhira,
S. Shafti-Keramat,
O. Forslund, M. Favre,
R. Kirnbauer
31. Different mechanisms
of immunosuppression
caused by
Cyclosporine A (CsA)
and FK506
T. Giese, C. Sommerer,
C. Jacobi, M. Zeier,
S. Meuer
32. Identification of three
novel genes as
biomarker for monitoring
anti-TGFbeta therapy
S. Classen, C. Muth,
D. Eggle, M. Beyer,
T. Zander,
A. Staratschek-Jox,
J. L. Schultze
39. Skin dendritic cells
present lipid antigens to
natural killer T cells
P. Stoitzner,
I. F. Hermans,
N. Romani

Scientific Programme – Thursday, September 4, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
14.00
-
15.30
T-Lymphocytes II
Chair: M. Lohoff,
A. Thiel
40. Stability and flexibility
of CD4 T cell differentiation
programs in vitro
and in vivo
A. N. Hegazy,
H. Hengartner,
R. M. Zinkernagel,
A. Radbruch,
M. Löhning
41. On the role of
adipokines in Th2 lymphocyte
polarization
A. Batra, B. Okur, J.
Ihbe, T. Stroh,
R. Glauben, I. Fedke,
M. Zeitz, B. Siegmund
42. In vivo generated
Th17 cells have a stable
memory for IL-17 expression
M. H. Lexberg,
I. Albrecht, A. Förster,
A. Richter, A. Radbruch,
H. D. Chang
43. Role of HDAC in T
helper cell development
R. Glauben,
E. Sonnenberg, I. Fedke,
P. Mascagni, M. Zeitz,
B. Siegmund
44. Human
CD4 + CD25 + Foxp3 + regulatory
T cells efficiently
inhibit GvHD induction in
a humanized mouse
model
C. Becker, J. Kubach,
C. Taube, C. Becker,
K. Michel, K. Reifenberg,
H. Jonuleit
45. Mathematical modeling
of the diversity of the
immunological synapse
M. T. Figge,
M. Meyer-Hermann
Vaccines & Adjuvants
Chair: B. Grubeck,
S. Weiss
48. Improvement of the
Immunogenicity of a
HIV-1 Clade C Candidate
Vaccine increasing
Gag, Pol, Nef and Env
Specific T-Cell Responses
J. Wild, J. Koestler,
S. Bredl, K. Boeckl,
R. Wagner
49. Safety and immunogenicity
in a phase I
dose-escalation BPV-1
VLP vaccine trial in
horses
R. Kirnbauer, S. Brandt,
S. Shafti-Keramat,
E. K. Hainisch
50. Characterisation of
effects on growth of
Staphylococcus aureus
mediated by specific
IgGs
B. Tosetti, E. Glowalla,
M. Krönke, O. Krut
51. Analysis of the
mechanisms mediating
dendritic cell-based vaccination
against Leishmania
major
J. K. Schnitzer,
C. Hambrecht,
M. Fajardo-Moser,
K. A. Remer,
H. Moll
52. Virus-like particles: A
cell-free antigen-presenting
platform modulating
lymphocyte
activation in vitro and in
vivo
H. J. Kueng, V. M. Leb,
D. Haiderer, G. Raposo,
C. Thery, S. V. Derdak,
K. G. Schmetterer,
A. Neunkirchner,
C. Sillaber, B. Seed,
W. F. Pickl
53. Priming and boosting
of melanA-specific T
cells - in vitro studies on
the importance of antigen-presentation
density
J. Dörrie, N. Schaft,
V. Wellner, C. Wohn,
T. Schunder, I. Müller,
E. Kämpgen, G. Schuler
Signal Transduction
Chair: T. Bürckstürmer,
T. Stulnig
56. Oxidation of cofilin
mediates T cell hyporesponsiveness
under oxidative
stress conditions
M. Klemke, G. Wabnitz,
F. Funke, B. Funk,
H. Kirchgessner,
Y. Samstag
57. The orphan adapter
protein SLY1 as a novel
anti-apoptotic protein required
for thymocyte development
B. Reis, D. Finkenstaedt,
D. K. Finlay,
D. A. Cantrell, K. Pfeffer,
S. Beer
58. Micropatterning of
CD4 in the live cell
plasma membrane reveals
novel binding
mechanisms to Lck
M. Schwarzenbacher,
M. Kaltenbrunner,
M. Brameshuber,
C. Hesch, W. Paster,
J. Weghuber, B. Heise,
A. Sonnleitner, H. Stokkinger,
G. J. Schütz
59. Stat3 serine 727
phosphorylation upon
activated TLR binding
promotes via
MyD88/TRIF safekeeping
of IL-1beta
S. Dreher, F. Schmitz,
R. Ferstl, S. Spiller,
J. Marges, A. Heit, I. Förster,
R. Lang, H. Wagner,
C. J. Kirschning
60. Carma1/Bcl10/Malt1
Complexes Transmit
ITAM-coupled NK Cell
Receptor Signals for NF-
B and MAPK Activation
O. Groß, C. Grupp,
C. Steinberg,
S. Zimmermann,
D. Strasser,
N. Hannesschläger,
W. Reindl, C. Peschel,
A. Krug, J. Ruland
61. Functional analysis
of the riboflavin kinase
and its role in TNF-induced
signalling
B. Yazdanpanah,
C. Pongratz,
K. Wiegmann,
H. Kashkar, M. Krönke
NK cells
Chair: C. Watzl,
M. Fischer
64. The stress-inducible
endogenous danger signals
HSP70 and MICA
synergistically activate
the cytotoxic effector
functions of human NK cells
L. Elsner, P. F. Flügge,
J. Lozano, V. Muppala,
S. Y. Demiroglu,
D. Malzahn, H. Bickeböller,
G. Multhoff, L. Walter,
R. Dressel
65. Regulation of NK cell
activity through extracellular
HLA-B-Associated
Transcript 3
E. Pogge von Strandmann,
V. Simhadri,
K. S. Reiners,
H. P. Hansen, A. Engert
66. Natural killer cell’s
activation by Immunomodulin
for treatment
strategy of
recurrent genital herpes
V. Garib, U. Djabborov,
Y. Rasul-Zade
67. Decision making in
NK cells
D. Urlaub, S. Mesecke,
H. Busch, R. Eils,
C. Watzl
68. Natural killer cells are
modulated in patients
with neuroimmunologic
disorders in response to
treatment with intravenous
immunoglobulin
C. Jacobi, M. Claus,
B. Wildemann,
J. Römisch, C. Watzl,
S. Meuer, T. Giese
69. Myeloid-Derived
“Suppressor” Cells express
Rae-1 and activate
NK cells
A. Cerwenka,
E. Schlecker, I. Galani,
N. Nausch
12
Veterinary Immunology
Chair: A. Saalmüller,
M. Müller
72. Charakterization of
the chicken CD40-
CD40L system unsing
the RCAS retroviral gene
transfer technology
K. Schenk-Weibhauser,
J. Young, B. Kaspers,
S. Kothlow
73. Analysis of potential
antiviral MX activity in
the chicken
B. Schusser, N. Penski,
A. Reuter, G. Kochs,
P. Staeheli, B. Kaspers,
S. Kothlow
74. MHC typing in swine:
SLA class I and class IIallele
distribution in Austrian
Large White,
Landrace, and Pietrain
breeding stocks
S. E. Hammer,
J. Deutsch,
B. C. Rütgen, S. Groiß,
W. Gerner,
S. Müller, A. Saalmüller
75. Porcine coccidiosis -
adaptive immune response
mechanisms
against Isospora suis
H. L. Worliczek,
W. Gerner, A. Saalmüller,
A. Joachim
76. Potential diagnostic
markers for subclinical
endometritis in cows:
TNF-alpha, IL-1 alpha,
IL-1 beta, and IL-8
C. Gabler, M. Drillich,
C. Fischer, C. Holder,
W. Heuwieser,
R. Einspanier
77. Toll-like receptor expression
and bacterial
strain dependent
chemokine response in a
primary bovine colonic
epithelial cell culture
model
P. S. Bridger, M. Mohr,
J. Fröhlich, H. Metcalfe,
D. Werling, G. Baljer,
C. Menge

Scientific Programme – Thursday, September 4, 2008 (continued)
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
15.30
-
16.30
46. The role of the zinc
finger protein MAZR in
CD4/CD8 cell fate decisions
during thymocyte
development
S. Sakaguchi, I. Bilic,
M. Hombauer,
A. Schebesta,
W. Ellmeier
47. 2D-DIGE analysis of
enriched secretory lysosomes
of human T and
NK cells
H. Schmidt, C. Gelhaus,
M. Lettau,
M. Nebendahl,
M. Leippe, O. Janssen
54. Propagation-deficient
LCMV-derived vaccine
vector efficiently
targets dendritic cells to
induce potent T and B
cell responses against
immunogens of choice
L. Flatz, A. N. Hegazy,
A. Verschoor,
A. Bergthaler,
M. Löhning,
D. D. Pinschewer
55. Vaccination with
MHC class II-heterologous
dendritic cells induces
protective
immunity against Leishmania
major
K. A. Remer, H. Moll
62. The DEAD-box helicase
DDX3X is a critical
component of the TANKbinding
kinase 1-dependent
innate immune
response
D. Soulat,
T. Buerckstuemmer,
S. Westermayer,
A. Goncalves, A. Bauch,
A. Stefanovic,
O. Hantschel,
K. L. Bennett, T. Decker,
G. Superti-Furga
63. Post-transcriptional
regulation of FasL expression:
Molecular insights
into storage,
activation-induced mobilization
and shedding
of a prototypic death
factor
M. Lettau, O. Janssen
Coffee Break / Poster Viewing / Exhibition
70. Characterization of a
novel, RORgt-expressing
mucosal NK cell population
S. L. Sanos, A. Mortha,
V. Bui, K. Oberle,
A. Diefenbach
71. Specificity of interaction
between killer cell
immunoglobulin-like receptors
(KIR) and MHC
class I molecules of the
rhesus macaque
(Macaca mulatta)
P. Kruse, C. Rosner,
M. Hermes, L. Walter
13
78. Analysis of CD28 in
horses and application
of a polyclonal Ab to induce
co-stimulation
S. Ibrahim,
E. Abd El-Gawad,
F. Steinbach
79. Species-specific
generation of immune
regulatory molecules by
host pathogen coevolution
R. Kammerer, T. Popp,
S. Haertle, B. B. Singer,
E. Travanty, Z. Qian,
K. V. Holmes,
W. Zimmermann

Scientific Programme – Thursday, September 4, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3
16.45
-
18.00
Parallel Symposium 2:
Vaccination
Chair: M. Müller, H.J. Schild
Delineation of plasmablast characteristics
generated in steady-state and in systemic
immune responses
H. Mei
Towards a coronavirus- based multigene
vaccine platform
B. Ludewig
Modulating Vaccine Responses with
Innate Immunity
B. Pulendran
19.00 Welcome Reception at the Vienna City Hall
Parallel Symposium 2:
In Vivo Imaging
Chair: C. Scheinecker, C. Berek
The In Situ Dynamics of Innate and Adaptive
Immune Cell Behaviour Revealed By
Intravital Multiphotometry Microscopy
R. Germain
In vivo imaging of Germinal Center B Cells
A.E. Hauser
Non-invasive imaging of inflammation -
the quest for specificity
A. Wunder
NUDIST COLONIES.
CD-1-nude • NMRI-nude • BALB/c-nude
We’ve improved the availability of our nude mouse strains.
For more information, please contact us at:
Call: +49 (0) 9761/ 406-0 • +31 (0) 43 40 77 310
E-mail: dbestell@crl.com • nlbestel@crl.com
scand@criver.de
Parallel Symposium 2:
Immunomodulation
Chair: W. Ellmeier, E. Schmitt
Probing Dendritic cell In vivo Functions
S. Jung
Tec kinases in T cell activation and
function
L. Berg
14
Inducible Foxp3-dependent or -independent
human CD4+ regulatory T Cells.
R. Bacchetta

Scientific Programme – Friday, September 5, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3
08.15
-
09.30
09.30
-
10.30
Parallel Symposium 1:
Innate Immunity: Regulation
Chair: M. Säemann, W. Solbach
Innate resistance, inflammation, and
cancer
G. Trinchieri
Interferon regulatory factors and innate
immunity in early life
M. Goldman
The mammalian target of rapamycin and
innate immunity
T. Weichhart
Parallel Symposium 1:
Mucosal Inflammation
Chair: B. Bohle, D. Männel
Role of epithelial barrier function in allergy
P. Brandtzaeg
A prominent role for mucosal cystine/cysteine
metabolism in intestinal immunoregulation
S. Meuer
Tumor Necrosis Factor and the consequences
of its ablation in vivo
S. Nedospasov
Coffee Break / Poster Viewing / Exhibition
Parallel Symposium 1:
Transplantation
Chair: T. Wekerle, R. Schmidt
Antibody-mediated transplant rejection
G. Böhmig
15
Immune monitoring and therapy in transplantation
- from bench-to -bedside
H.D. Volk
Tolerance through mixed chimerism: how
close to clinical application is it?
T. Wekerle

Scientific Programme – Friday, September 5, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
10.30
-
12.15
Allergy I
Chair: H. Renz,
F. Horak
80. Tracing antigen signatures
in the human
IgE repertoire
K. Marth,
M. Novatchkova,
M. Focke-Tejkl,
S. Jenisch, S. Jäger,
D. Kabelitz, R. Valenta
81. Stable dust challenge
inhibits allergic airway
reactivity through
TLRs 2, 3, 4, 7, 9 and/or
other PRRs/TLRs
R. Ferstl, S. Spiller,
S. Dreher, H. Garn,
H. Fehrenbach,
E. Von Mutius, H. Renz,
H. Wagner,
C. J. Kirschning
82. Composition of B
cell receptor classic antigen-binding
site regulates
allergic airway
inflammation in a murine
model of experimental
asthma
S. Kerzel, J. Wagner,
T. Rogosch, A. Yildirim,
H. Fehrenbach, H. Garn,
R. F. Maier,
H. W. Schroeder Jr.,
M. Zemlin
83. High expression of
inflammatory cytokines,
chemokines and their receptors
in lungs of mice
during allergic asthma
remission underlies the
persistence of chronic
lung inflammation
R. Bankoti,
L. El-Housseiny,
G. Dekan, O. Hoffmann,
G. Stingl, M. M. Epstein
84. Antigen -specific immunotherapy
inhibited
Th2 via GATA-3 and
Th17 cells in an allergic
asthma model.
N. Zhivkova, R. Karwot,
J. H. Maxeiner,
P. Scholtes, K. Soo,
S. Finotto
85. Selective depletion
of Foxp3+ cells in
DEREG mice allows
functional analysis of
regulatory T cells during
experimental allergic airway
inflammation
A. Hartl, K. Lahl,
H. Hamad, A. Ö. Yildirim,
H. Fehrenbach, R. Teich,
H. Garn, H. Renz,
B. Lambrecht,
T. Sparwasser
Regulatory Lymphocytes
I
Chair: L. Klein,
T. Wekerle
88. Analyses of a novel
regulatory T cell subset
in patients with Systemic
Lupus Erythematosus
(SLE)
M. Bonelli,
A. Savitskaya, E. Feierl,
S. S. Smolen,
C. Scheinecker
89. CD4 + CD25 high regulatory
T cells suppress T
helper 1 but not T helper
2 cytokines
T. Bollinger,
A. Bollinger, W. Solbach
90. Induction of CD25 -
Foxp3 - regulatory T cells
by chronic antigen stimulation
in vivo
W. Hansen,
A. M. Westendorf,
J. Buer
91. Transfer of in vitro
expanded human
CD45RA+CD4+CD25hig
h regulatory T cells inhibits
early expansion of
conventional T cells in
immunodeficient Rag2-/c-/-
mice
T. J. Boeld, J. Albrecht,
K. Doser, R. Eder, J. Stahl,
E. Typlt, E. Obermann,
R. Andreesen,
P. Hoffmann, M. Edinger
92. Long-term vaccination
efficiency is independent
of regulatory T
cells
G. Gasteiger,
W. Kastenmuller,
L. Stross, D. H. Busch,
T. Sparwasser, I. Drexler
93. Retrovirally transduced,
antigen-specific
T cells for therapy of
type 1 diabetes
N. Mpofu, N. Saal,
M. Hardtke-Wolenski,
M. P. Manns, E. Jaeckel
Alloimmunity & Tolerance
Chair: B. Arnold,
H. Ankersmit
96. Role of IL-2 in induction
of CD8 T cell tolerance
by LSEC
A. K. Schurich, M. Berg,
A. Limmer, H. J. Schild,
L. Diehl, P. A. Knolle
97. Proliferation of CD8positive
T cells in the Lumina
of Rat Renal
Allograft Blood Vessels
V. Grau, G. Fuchs-Moll,
W. Padberg
98. Dickkopf 3, a novel
modulator of T cell responses
M. Papatriantafyllou,
G. Moldenhauer,
H. J. Gröne, C. Niehrs,
G. J. Hämmerling,
T. Oelert, B. Arnold
99. Toag-1 enables prediction
of CMV mediated
transplant tolerance abrogation
W. Gong, M. Klöpfel,
K. Vogt, S. Haase,
A. Reutzel-Selke,
H. Volk, A. Pascher,
B. Sawitzki
100. Mutated CYLD affects
the functional state
of dendritic cells
M. Bros, N. Wiechmann,
V. Besche,
N. Hövelmeyer,
S. Reissig,
S. Grabbe, A. Waisman,
A. B. Reske-Kunz
101. Enhanced nuclear
export of NFATc1 and
impaired translocation of
NFATc2 is observed in
anergic iTreg generated
by tolerogenic DC
H. S. Adler, R. Orth,
K. Streck, E. Graulich,
K. Steinbrink
Pattern Recognition
Receptors & Myeloid
Cells
Chair: S. Bauer,
C. Bogdan
104. Influence of viral infection
on recognition of
self RNA
T. von Thülen, M. Nain,
S. Bauer
105. TLR7-dependent
recognition of transfer
RNA
Y. Zhao, A. Kaufmann,
K. Steinbach, S. Bauer
106. Intrabody mediated
retention of TLR2 and
TLR9 in the ER to inhibit
chronic inflammation
T. Böldicke, S. Dreher,
S. Somplatzki,
L. Grosse-Hovest,
B. Maaß,
W. Lindenmaier,
H. Wagner,
C. Kirschning
107. Analysis of Toll-like
receptor 7 and Toll-like
receptor 9 chimeric molecules
J. Willemsen, P. Yu,
S. Bauer
108. The divergent role
of the mammalian target
of rapamycin (mTOR) in
dendritic cells subtypes
M. Haidinger,
T. Weichhart,
M. Poglitsch, M. Hecking,
M. Zeyda, R. Geyeregger,
J. Werzowa, W. H. Hörl,
M. D. Säemann
109. Mammalian target
of rapamycin (mTOR) orchestrates
the defense
program of innate immune
cells
F. Schmitz, A. Heit,
S. Dreher, K. Tittel,
J. Mages, T. Haas,
A. Krug, K. Janssen,
C. V. Kirschning,
H. Wagner
Innate Immunity:
Regulation
Chair: M. Zeyda,
K. Pfeffer
16
112. Suppression of
adaptive immune responses
by Toll-like receptor
ligands
B. Schumak, M. Brock,
F. Jüngerkes,
G. Hartmann, T. Tüting,
P. Knolle, R. Zawatzky,
S. Bauer, A. Limmer
113. The cytoplasmic tail
of CD45 is released from
activated phagocytes
and can act as an inhibitory
messenger for
T cells
S. Kirchberger,
O. Majdic, S. Blüml,
C. Schrauf, J. Leitner,
C. Gerner, W. Paster,
N. Gundacker, M. Sibilia,
J. Stöckl
114. Molecular mechanisms
of Staphylococcus
aureus-induced autophagy
K. Sabel, D. Grumme,
S. A. Leggio,
A. Schnaith, M. Krönke,
O. Krut
115. 12/15-lipoxygenase
is involved in the limitation
of inflammation and
tissue damage in murine
arthritis
G. Krönke,
J. Katzenbeisser,
S. Uderhardt, W. Baum,
R. Axmann, J. Zwerina,
G. Schett
116. Promoter methylation
status is changed
with altered DEFB1 gene
expression in COPD
E. Andresen,
J. Bullwinkel, C. Lange,
H. Heine
117. Macrophage phosphoproteome
dynamics
after LPS-stimulation
and its shaping by the
MAPK-Phosphatase
DUSP1: a SILAC-based
approach
G. Weintz, J. Olsen,
J. Mages, M. Mann,
R. Lang

Scientific Programme – Friday, September 5, 2008 (continued)
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
86. Molecular and functional
analysis of the
antigen receptor of Bet v
1-specific helper T lymphocytes
A. Neunkirchner,
V. M. Leb,
K. G. Schmetterer,
H. J. Kueng, D. Haiderer,
S. Mutschlechner,
B. Bohle, W. F. Pickl
87. Cloning, expression
and mapping of allergenic
determinants of
alphaS1-casein, a major
cow’s milk allergen
U. Schulmeister,
H. Hochwallner,
I. Swoboda, M. Focke-
Tejkl, M. Nystrand,
A. Harlin, J. Thalhamer,
S. Scheiblhofer, W. Keller,
B. Niggemann, S. Quirce,
C. Ebner, A. Mari,
G. Pauli, B. Geller,
U. Herz, R. Valenta,
S. Spitzauer
Time Lecture Hall 2
12.15
-
13.45
94. BAC-transgenic mice
for depletion of Foxp3 +
regulatory T cells:
Homeostatic expansion
of Tregs
J. Suffner,
K. Hochweller, N. Garbi,
G. Hämmerling
95. Lack of Foxp3 Treglinage
marker expression
in mouse epithelial cells
C. T. Mayer, K. Lahl,
C. Loddenkemper,
T. D. Sparwasser
102. Allogeneic disparities
in the surface molecule
immunoglobulin-like
transcript 5 (ILT-5) induce
potent antibody responses
in stem cell
transplanted patients
K. Pfistershammer , ,
A. Lawitschka, J. Leitner,
C. Klauser, R. Weigl,
G. Böhmig, G. F. Fischer,
M. Heemskerk,
O. Majdic, W. F. Pickl,
H. Greinix, P. Steinberger
103. Dendritic cell-activated,
endothelial cellspecific
CTL recognizing
a minor histocompatibility
antigen rapidly induce
transplant vasculopathy
B. B. Bolinger,
D. Engeler, P. Krebs,
S. Miller, B. Ludewig,
M. Hoffmann, P. Clavien,
Y. Tian
110. Hsp60 modulates
neutrophil functions
A. Osterloh,
M. Piedavent,
F. Geisinger,
B. Fleischer, N. Brattig,
M. Breloer
111. Spatial separation
of cross-presentation
and endogenous antigen
presentation
S. Burgdorf, C. Schölz,
A. Kautz, R. Tampé,
C. Kurts
Satellite Lunch Symposium - Octapharma
Immune modulation with intravenous immunoglobulin: the established and the advances
Chair: S. Meuer
17
118. Prophylactic blockade
of TLR4 or therapeutic
blockade of both
TLR2 and TLR4 protects
mice from Gram-negative
infection and subsequent
antibiotic therapy
induced fatal septic
shock
C. J. Kirschning,
G. Elson, R. Ferstl,
S. Dreher, T. Müller,
M. Freudenberg,
B. Daubeuf, H. Wagner,
S. Spiller
119. Biological characterization
of mouse beta
defensin 14 - an orthologue
of human beta
defensin 3
J. Röhrl, T. Hehlgans
Immunthrombocytopenia as the first model for biological treatment with IVIG in chronic inflammatory and autoimmune diseases
P. Imbach
Intravenous Immunoglobulins: mechanisms of action and options for improvement of therapeutic efficacy
F. Nimmerjahn
Basic research in human immunology creates new therapeutic options
S. Meuer
Discussion and wrap-up
Time Lecture Hall 1
13.00
-
13.45
Drittmittelförderung der DFG: Kriterien für eine erfolgreiche Antragstellung
Chair: Y. Samstag
A. Strecker

Scientific Programme – Friday, September 5, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
14.00
-
15.30
Infection I
Chair: F. Schmitz,
S. Ehlers
120. Restricted B cell receptor
diversity converts
acute into chronic viral
infection
A. Bergthaler, L. Flatz,
A. Verschoor,
A. N. Hegazy,
E. Horvath, M. Holdener,
K. Fink, B. Odermatt,
D. D. Pinschewer
121. Interleukin 18 is essential
for protective immunity
against M.
tuberculosis.
B. Schneider,
D. Korbel, K. Hagens,
M. Koch,
S. H. Kaufmann,
H. Mittruecker,
U. E. Schaible
122. Wnt/Frizzled signaling
in infectious diseases:
Deciphering the
role of FZD1 in mycobacterial
infections
N. Reiling,
T. Endermann, S. Ehlers,
J. Neumann
123. Cavity formation in
tuberculosis is mediated
by interleukin-4 receptor-alpha-dependent
mechanisms
L. Heitmann,
T. Schreiber, T. Thye,
A. N. McKenzie,
A. Cutler, F. Brombacher,
R. D. Horstmann,
C. G. Meyer, S. Ehlers,
C. Hoelscher
124. Immunological inhibition
of gC1qR/p33, a
receptor for C1q, decreases
adherence of
Staphylococcus aureus
to microvascular endothelium
S. Sethi, M. W. Laschke,
J. Roller, L. von Mueller,
E. Peerschke,
B. Ghebrehiwet, I. Bajric,
M. D. Menger,
M. Herrmann
125. The fibrin-derived
peptide B 15-42 (FX06)
for treatment of capillary
leak
M. Gröger, W. Pasteiner,
G. Ignatyev, U. Matt,
S. Knapp, P. Friedl,
D. Zinkl, K. Zacharowski,
R. Hofer-Warbinek,
P. Petzelbauer,
S. Reingruber
Allergy II
Chair: B. Linhart,
G. Stary
128. HLA-classII/peptide-TCR
interactions of
the single immunodominant
T cell epitope of Art
v 1, the major mugwort
pollen allergen
B. Jahn-Schmid,
B. Maillere, V. Leb,
W. Pickl, G. Gadermaier,
F. Ferreira, B. Bohle
129. Proteomic analysis
and mass-spectrometric
identification of differentially
regulated proteins
in primary human keratinocytes
by allergens
S. Ohnesorge, L. Dietz,
P. Pankert,
M. Schnoelzer,
H. Thierse
130. Immunosuppression
and allergy in organ
transplant recipients: evidence
for insufficient
control of allergen specific
responses
T. Eiwegger, S. Gruber,
C. Geiger, E. Dehlink,
T. Frischer, P. Jaksch,
W. Klepetko,
Z. Szépfalusi
131. Long-term tolerance
in IgE-mediated allergy
through molecular
hematopoietic
chimerism in a murine
model
U. Baranyi, B. Linhart,
N. Pilat, M. Gattringer,
C. Klaus, E. Schwaiger,
F. Muehlbacher,
J. Iacomini, R. Valenta,
T. Wekerle
132. Generation of an
IgE knock-in mouse and
its use in systemic anaphylaxis
in vivo
P. Yu, W. Lübben,
S. Bauer
133. Murine plasma and
non-plasma B cells express
different IgE repertoires
T. Rogosch, S. Kerzel,
L. Sikula, R. Maier,
M. Zemlin
Regulatory Lymphocytes
II
Chair: A. Rosenkranz,
H. Schulze-Koops
136. Generation of induced
CD8+Foxp3+ regulatory
T cells in vitro
C. Mayer, K. Lahl,
D. Dittlein, V. Wenzel,
O. Gassner, J. Stephani,
C. Loddenkemper,
T. Sparwasser
137. CD8 + CD38 + T-cells:
A competent regulatory
T-cell population
A. Bollinger,
H. Fehrenbach,
T. Bollinger, T. Bollinger,
Z. Orinska,
S. Bulfone-Paus
138. Tolerogenic potential
of lentivirally transduced
murine DC
overexpressing antiinflammatory
molecules
V. Besche,
N. Wiechmann,
S. Trojandt, S. Grabbe,
A. B. Reske-Kunz,
M. Bros
139. IL-27 inhibits the
development of regulatory
T cells via STAT3
M. Huber, V. Steinwald,
A. Guralnik, A. Brüstle,
P. Kleemann,
C. Rosenplänter,
T. Decker, M. Lohoff
140. Development of
“would-be” regulatory T
cells and defective control
of Th2-cytokine production
in natural scurfy
mutant mice
K. I. Lahl, C. T. Mayer,
J. Huehn, C. Loddenkemper,
G. Eberl,
J. Buer, T. Sparwasser
141. TLR2 ligands act
directly on Treg to abrogate
suppression of
CD4+CD25- T cells
H. Oberg, M. Juricke,
S. Ussat, H. Ly,
D. Kabelitz, D. Wesch
Mucosal Immunity
Chair: R. Förster,
M. Pasparakis
144. Role of the transcription
factor PU.1 in
human lamina propria
macrophages
F. A. Lasitschka,
A. Heidtmann, T. Giese,
G. Wabnitz,
A. Schrödter, J. Winter,
A. Ulrich, S. C. Meuer,
J. Schröder-Braunstein
145. Role of eosinophils
in TGF-beta expression
in human intestine
F. Ulmer, S. C. Bischoff,
A. Lorentz
146. CD4 + Foxp3 + regulatory
T cell expansion
induced by antigen-driven
interaction with intestinal
epithelial cells
independent of local
dendritic cells
A. M. Westendorf,
D. Fleissner, S. Jung,
A. D. Gruber, W. Hansen,
J. Buer
147. Split tolerance after
oral vaccination of mice
with recombinant Escherichia
coli Nissle
1917 expressing fimbrial
adhesin K88
K. A. Remer,
M. Bartrow, H. Moll,
T. A. Oelschläger
148. The role of IL-23/IL-
17 in Toxoplasma gondii
induced small intestinal
immunopatology
M. L. Munoz-Roldan,
D. Struck, M. Heimesaat,
C. Hoelscher, U. Mueller,
Y. Iwakura, N. Ghilardi,
O. Liesenfeld
149. The mesenteric
lymph node regulates
the amplitude of IgA
secretion in the drained
area: potential role of the
spleen in the immune
response against orally
applied cholera toxin
A. Hahn, N. Thiessen,
R. Pabst, M. Ahrendt,
U. Bode
B-Lymphocytes
Chair: V. Sexl,
T. Winkler
18
152. Swiprosin 1 - positive
regulator of BCR induced
calcium flux
C. Kroczek, C. Lang,
A. Avramidou,
L. Nitschke, A. Elter,
H. M. Jäck, D. Mielenz
153. Engagement of
CD83 on B cells augments
IgG1 response in
vivo
B. Kretschmer,
K. Lüthje,
S. Schneider,
B. Fleischer, M. Breloer
154. The analysis of intravital
two-photon imaging
of germinal
centres implies a novel
lymphocyte migration
and affinity maturation
model
M. Meyer-Hermann,
M. Figge
155. Proapoptotic BH3only
proteins Bim and
Puma are essential for
apoptosis of germinal
center-derived memory
B cells and antibodyforming
cells
S. Fischer , , D. Tarlinton,
A. Strasser
156. Identification of a
chemokine receptor profile
characteristic for mediastinal
large B-cell
lymphoma
U. E. Höpken,
I. Anagnostopoulos,
M. Broemer,
C. Scheidereit,
K. Joehrens, M. Hübler,
H. Stein, M. Lipp,
B. Dörken, A. Rehm
157. The adapter protein
SLy2 represents a newly
identified regulator of cytoskeletalrearrangements
M. L. von Holleben

Scientific Programme – Friday, September 5, 2008 (continued)
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
15.30
-
16.30
Time Lecture Hall 2
18.00
-
19.30
175. Immunopathological
basis of lymphocytic
choriomeningitis virusinduced
chorioretinitis
and keratitis
M. Zinkernagel, P. Krebs,
B. Bolinger, S. Miller,
B. Ludewig
127. CD8 T cell-mediated
immune responses
against cross-presenting
liver sinusoidal endothelial
cells leads to hepatitis
D. Stabenow,
K. Gärtner, M. Svorcova,
M. Odenthal, H. Dienes,
U. Protzer, P. A. Knolle
General Assembly DGfI
Chair: S. Meuer
134. Induced ablation of
mast cells in adult mice:
Slow recovery of mast
cell populations in the
tissues.
J. Scholten,
A. Gerbaulet, B. Hiller,
W. Muller, T. Krieg,
T. Buch, A. Waisman,
K. Hartmann, A. Roers
135. Timothy grass
pollen major allergen Phl
p 1 - a protease?
K. Röschmann,
P. König, A. J. Ulmer,
A. Petersen
142. Influence of
CD4+CD25+ regulatory
T cells on the
transendothelial migration
of CD4+CD25- T
cells
T. Bedke, M. Kretz,
K. Mahnke, A. H. Enk
143. Expansion of immune-suppressive
V 9V 2 T cells as a novel
regulatory mechanism of
IL-12 secreting dendritic
cells
M. W. Traxlmayr,
A. M. Dohnal, D. Wesch,
D. Kabelitz, T. Felzmann
Coffee Break / Poster Viewing / Exhibition
150. The role of CXCR5
in antigen-independent
development and antigen-dependentmaturation
of nose-associated
lymphoid tissue (NALT)
J. Krege, S. Seth,
S. Hardtke, A. Marques
Davalos-Misslitz,
R. Förster
151. T cell-specific deletion
of gp130 renders
the highly susceptible Interleukin-10
deficient
mouse mutant resistant
to intestinal nematode
infection
N. Fasnacht,
M. C. Greweling,
M. Bollati-Fogolin , ,
A. Schippers , , W. Müller ,
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3
16.45
-
18.00
Parallel Symposium 2:
Infection
Chair: S. Knapp, I. Förster
Origin of CD8+ effector and memory T cell
subsets
D.H. Busch
Mutual host pathogen reactions in tuberculosis
U. Schaible
Innate immune response to pneumococcal
pneumonia
S. Knapp
Parallel Symposium 2:
Adaptive Immunity: Regulation
Chair: H. Stockinger, L. Klein
Innate and adaptive IL-17 in the control of
immune responses
B. Stockinger
Autoregulatory circuits in inflammatory
T cell responses
A. Scheffold
Innate Immunity in regulation of antibody
mediated inflammation
R.E. Schmidt
19.30 Departure with buses to the Viennese “Heuriger” Fuhrgassl-Huber
19
158. Antigen receptor tail
clue of class-switched
memory B cells
N. Engels, C. Heemann,
L. König, T. Tsubata,
S. Griep, V. Schrader,
J. Wienands
159. Role of basophils in
immunological memory
responses
A. J. Denzel, U. Maus,
M. Rodriguez Gomez,
M. Niedermeier, Y. Talke,
N. Göbel, M. Mack
Parallel Symposium 2:
Adaptive Immunity: B-Cells
Chair: G. Zlabinger, H-M. Jäck
Transcriptional control of B cell development
M. Busslinger
Memory B cell sub-populations
J.C. Weill
Plasma cell memory
A. Radbruch

Scientific Programme – Saturday, September 6, 2008
Time Lecture Hall 1 Lecture Hall 2 Lecture Hall 3
08.45
-
10.00
10.00
-
10.30
Your Power for Health
Parallel Symposium 1:
Autoimmunity
Chair: J. Smolen, H. Schulze-Koops
The life history of an autoimmune driver
clone
E. Sercarz
Immunopathogenesis of rheumatoid arthritis:
induction of arthritogenic autoimmune
reactions by proinflammatory stimuli
G. Steiner
Modeling multiple sclerosis: autoimmune
T and B cells in the pathogenesis of the
brain inflammatory disease
H. Wekerle
Moderne Antikörper-Analyse
Immunologische Produkte
von Greiner Bio-One
Gleichbleibende und reproduzierbare
Bindung von Proteinen
Geeignet für Transmissions-, Fluoreszenz-
und Lumineszenzmessungen
Konstante, einheitliche Bindungseigenschaften
Vielfältiges Spektrum an Microplatten
und Streifen-Platten
Kompatibel mit automatisierten Systemen
Parallel Symposium 1:
Inflammation
Chair: J. Stöckl, K. Pfeffer
Mechanisms of inflammatory bone
destruction
K. Redlich
Novel cytokines in inflammatory diseases
F. Liew
IL-17 and kynurenines in pathogenic
inflammation
L. Romani
Coffee Break / Exhibition
Parallel Symposium 1:
Allergy
Chair: R. Valenta, J. Kalden
Human Th17 cells
S. Romagnani
Greiner Bio-One GmbH | Bad Haller Straße 32 | A-4550 Kremsmünster | Phone: (+43) 75 83 67 91-0 | Fax: (+43) 75 83 63 18 | E-Mail: offi ce@at.gbo.com
New facets in mast cell activation
S. Bulfone-Paus
From allergens to vaccines
R. Valenta
20
www.gbo.com/preanalytics

Scientific Programme – Saturday, September 6, 2008
Time Lecture Hall 2 Lecture Hall 3 Lecture Hall 4 Lecture Hall 5
10.30
-
12.15
Autoimmunity II
Chair: R. Schwinzer,
G. Staffler
160. CCR7 is essential for regulatory
T cell function in anti-
GBM glomerulonephritis
K. Hochegger, A. Rosenkranz,
A. Rot
161. The nuclear receptor
PPARgamma serves as an intrinsic
regulator of Th17 cell differentiation
L. Klotz , , I. Dani, S. Burgdorf,
A. Waisman, G. Eberl,
J. Alferink, B. Langhans,
T. Klockgether, P. Knolle
162. Spontaneous CD8+ T Cell
Mediated Liver Inflammation in
a Transgenic Mouse Model of
Autoimmune Hepatitis
M. Zierden, E. Kühnen,
M. Odenthal, H. P. Dienes
163. Peripheral T cells are the
therapeutic targets of highdose
glucocorticoids in experimental
autoimmune
encephalomyelitis
S. Wüst, J. van den Brandt,
J. P. Tuckermann, R. Gold,
H. M. Reichardt, F. Lühder
164. The proteasome inhibitor
bortezomib depletes plasma
cells and protects lupus mice
from nephritis
K. Neubert, S. Meister,
K. Moser, F. Weisel, D. Maseda,
K. Amann, T. H. Winkler,
J. R. Kalden, R. E. Voll
165. CD8 T cells specific for a
glomerular antigen induce renal
inflammation in a CD4 help dependent
fashion and may
cause progressing Glomerulonephritis
F. Heymann, E. E. Hamilton-
Williams, I. Ludwig-Portugall,
S. Quaggin, J. Flöge, H. Gröne,
C. Kurts
166. A new model for inflammatory
bowel disease: A transgenic
mouse expressing a
crossreactive T cell receptor
recognizing murine and bacterial
HSP60
N. Schmidt, T. Joeris,
U. Steinhoff
167. NAADP/Ca 2+ signaling: a
new therapeutic target for T cell
mediated autoimmune disease
F. Odoardi, C. Cordiglieri,
W. Dammermann, B. Zhang,
M. Hohenegger, B. V. Potter,
A. Guse, A. Flügel
Infection II
Chair: V. Leksa,
O. Sharif
168. Immunemodulation by
Siglec-E during Trypanosoma
cruzi infection
H. Erdmann, P. R. Crocker,
B. Fleischer, T. Jacobs
169. A novel Leishmania major
amastigote culture system
U. A. Wenzel, S. Möller,
M. Klinger, S. Liebau, T. Laskay,
G. van Zandbergen
170. The elimination of
Anaplasma phagocytophilum in
vivo requires CD4+ T cells, but
is independent of Th1 cytokines
and a wide spectrum of
effector mechanisms
K. Birkner, Y. Kern, B. Steiner,
C. Bogdan, F. D. von Loewenich
171. Oxidized phospholipids inhibit
phagocytosis via a PKA
dependent mechanism
U. Matt, O. Sharif, T. Furtner,
K. Stich, A. Zivkovic, S. Knapp
172. Control of Persistent HBV
Infection by Hepatitis B Core
Antigen-activated NK cells:
A Possible Mechanism for the
HBV Persistence
L. Huang, P. Chen, P. Knolle
173. Acute infection with a single
hepatitis C virus strain in
dialysis patients: analysis of
adaptive immune response and
its impact on viral sequence
evolution
L. Weseslindtner,
C. Neumann-Haefelin, S. Viazov,
A. Haberstroh, J. Kletzmayr,
J. H. Aberle, J. Timm,
S. R. Ross, R. Klauser-Braun,
T. F. Baumert, M. Roggendorf,
R. Thimme, H. Holzmann
174. Type I Interferons as virulence-determining
factors in
Listeria monocytogenes infections
B. Reutterer, S. Stockinger,
A. Pilz, D. Soulat, R. Kastner,
S. Westermayer, T. Rülicke,
M. Müller, T. Decker
126. Yersinia enterocolitica differently
affects DC subpopulations
in vivo
S. E. Autenrieth, T. Linzer,
P. Warnke, S. Schmitz,
I. B. Autenrieth
Complement System
Chair: M. Kirschfink,
M. Wahrmann
176. Human factor H-related
protein 4 (CFHR4) recruits Creactive
protein to the surface
of necrotic cells
M. Mihlan, M. Hebecker,
M. Huber-Lang, R. Dahse,
P. F. Zipfel, M. Józsi
177. Regulation of mouse ficolin-B
expression in immune
competent cells
V. L. Runza, J. Kürchner,
D. Weber-Steffens,
D. N. Männel
178. Functional analyses indicate
pathogenic role of factor
H autoantibodies in atypical
hemolytic uremic syndrome
S. Strobel, P. F. Hoyer,
C. J. Mache, E. Sulyok,
P. F. Zipfel, M. Józsi
179. A dual role of the C5a receptor
(C5aR) in acute and
chronic dextran sulphate induced
models of inflammatory
bowel disease
K. Johswich, M. Martin,
A. Bleich, M. Kracht,
O. Dittrich-Breiholz, E. Gessner,
S. Suerbaum, C. Rheinheimer,
A. Klos
180. Candida albicans CaHGT1
and its role in complement inhibition
and modulation of other
virulence factors
I. Lesiak, G. Vogl,
T. Schwarzmüller, M. P. Dierich,
K. Kuchler, R. Würzner
P419. Characterization of factor
H binding to neutrophil granulocytes
J. Losse, P.F. Zipfel, M. Józsi
182. Rituximab-induced ADCC
of tumour cells is variably
modified by complement iC3b
A. Dörr, C. Watzl,
M. Kirschfink
Cytokines, Chemokines &
their receptors
Chair: U. Höpken,
M. Sibilia
21
183. gp130 on
macrophages/neutrophils negatively
regulates Th17 development
during experimental
tuberculosis
J. Sodenkamp, I. Foerster,
W. Mueller, C. Hoelscher
184. The role of optineurin
(FIP2) in adenovirus E3-14.7Kmediated
inhibition of TNFR1
apoptosis
L. Klingseisen, G. Knoll,
W. Schneider-Brachert
185. Overlapping functions of
IL-7 and TSLP in lymphoid development
D. Finke, L. Flueck, A. G. Farr,
A. G. Rolink, S. Chappaz
186. Organ-specific suppression
of CCL17 production
through Interferon-
T. Globisch, S. Stutte,
V. Lukacs-Kornek, C. Kurts,
I. Förster
187. Down-regulation of IFNduring
HPV-induced carcinogenesis
B. Rincon-Orozco, F. Rösl
188. An IFN reporter mouse
model for the visualization of
the initiation of the Type I interferon
response in vivo
P. Dresing, S. Scheu,
R. M. Locksley
189. Chemokine receptor CCR7
contributes to a rapid and efficient
clearance of lytic MHV-68
from the lung while bronchusassociated
lymphoid tissue harbors
virus during latency
J. R. Kocks, H. Adler,
H. Danzer, K. Hoffmann,
D. Jonigk, U. Lehmann,
R. Förster
190. IL-27 acts as a Priming
Signal on Human Keratinocytes
and Antigen- Presenting Cells
J. Zeitvogel, T. Werfel,
M. Wittmann

Immunity for Life
Immunology for Health
Venue
International Congress Center Berlin (ICC Berlin)
Neue Kantstraße / Ecke Messedamm
14057 Berlin, Germany
www.icc-berlin.de
Under the auspices of EFIS
2 nd European Congress
of Immunology
Congress President
Prof. Dr. med. Reinhold E. Schmidt
Medizinische Hochschule Hannover
Klinik für Immunologie und Rheumatologie
Carl-Neuberg-Straße 1
30625 Hannover, Germany
Phone: +49 (0)511– 532-6656
Fax: +49 (0)511– 532-9067
E-Mail: immunologie@mh-hannover.de
September 13 – 16, 2009
Berlin, Germany
Congress Secretariat
K.I.T. GmbH Association & Conference
Management Group & Co. KG
Kurfürstendamm 71
10709 Berlin, Germany
Phone: +49 (0)30 – 246 03-0
Fax: +49 (0)30 – 246 03-200
E-Mail: eci2009@kit-group.org
www.kit-group.org
www.eci-berlin2009.com

Scientific Programme – Saturday, September 6, 2008
Time Lecture Hall 1
10.30
-
12.45
12.45
-
13.00
Satellite Lunch Symposium - Phadia
Vom rekombinanten Allergen zu neuen Allergietherapien
Chair: R. Valenta, N. Reider
Rekombinante Allergene: Vom Beginn zur Gegenwart
H. Breiteneder
Rekombinante Nahrungsmittelallergene
K. Hoffmann-Sommergruber
Klinische Anwendungen für rekombinante Allergene
P. Schmid-Grendelmeier
Klinische Erfahrungen mit Allergenchips
J. M. Baron
Die Komplexitaet von zellulären Allergietesten
J. Kleine-Tebbe
Immuntherapie und Verlaufkontrolle mit rekombinanten Allergenen
G. Pauli
Pause (mit Snack)
Time Lecture Hall 1
13.00
-
13.45
14.00
-
14.30
Klinische Fälle aus der Allergologie: Wie hätten Sie entschieden?
Chair: Z. Szepfalusi, G. Pauli
Werner Aberer, Reinhart Jarisch, Felix Wantke und Stefan Wöhrl präsentieren klinische Fälle aus der Allergologie
Best Poster Awards
Chair: J. Smolen, S. Meuer
Time Lecture Hall 2
15.00 General Assembly ÖGAI
Chair: J. Smolen, M. Säemann
23

Warum soll ich in die Ferne schweifen,
wenn mir ein Diagnostik unternehmen
alles bietet, was ich brauche?
Siemens Healthcare Diagnostics. Das Engagement, um Ihren
individuellen Bedürfnissen auf den Grund zu gehen.
Oberste Priorität hat für Sie eine optimale Patientenbetreuung, und für uns, Ihnen dabei zu helfen, dieses
Ziel zu erreichen. Dazu bietet Ihnen Siemens ein beachtliches Portfolio leistungsorientierter Systeme, ein
umfangreiches Testmenü sowie innovative IT- und Servicelösungen an. Sprechen Sie mit unserem
Expertenteam über Ihre Vorstellungen – gemeinsam finden wir die optimale Lösung für Sie. Treten Sie
näher: www.siemens.com/customer-first
Answers for life.
A91DX-0701169-A1-0000 © 2008 Siemens Healthcare Diagnostics Inc. All rights reserved.

Poster Viewing 25
Thursday, September 4, 2008
09.30 – 10.30 hrs
T-Lymphocytes I
Chair: B. Jahn-Schmid, C. Scheinecker
P001 – P028
T-Lymphocytes II
Chair: W. Pickl, H. Stockinger
P029 – P056
Innate Immunity: Antigen-Presenting Cells
Chair: T. Weichhart, M. Gilliet
P057 - P075
Signal Transduction
Chair: L.J. Berg, W. Ellmeier
P076 - P094
Tumor Immunology
Chair: O.J. Finn, T. Blankenstein
P095 - P117
Thursday, September 4, 2008
15.30 – 16.30 hrs
Innate Immunity: Regulation
Chair: M. Zeyda, S. Beissert
P118 - P134
Pattern Recognition Receptors & Myeloid Cells
Chair: F. Schmitz, J. Stöckl
P135 - P151
NK Cells
Chair: C. Watzl, V. Sexl
P152 - P164
Vaccines & Adjuvants
Chair: H. Lassmann, T. Weichhart
P165 - P187
Immunomodulation
Chair: M. Fischer, G. Zlabinger
P188 - P208
Friday, September 5, 2008
09.30 – 10.30 hrs
Alloimmunity & Tolerance
Chair: G. Böhmig, M. Säemann
P209 - P233
Allergy
Chair: B. Bohle, S. Bulfone-Paus
P234 - P264
Infection
Chair: U. Schaible, S. Knapp
P265 - P296
Mucosal Immunity
Chair: S. Meuer, P. Brandtzaeg
P297 - P308
Friday, September 5, 2008
15.30 – 16.30 hrs
Autoimmunity I
Chair: R. Germain, E. Sercarz
P309 - P329
Autoimmunity II
Chair: G. Steiner, J. Kalden
P330 - P352
Complement System and B-Lymphocytes
Chair: F. Melchers, A. Radbruch
P420 and P353 - P360
Regulatory Lymphocytes
Chair: L. Klein, R. Bacchetta
P361 - P383
Cytokines, Chemokines & their receptors
Chair: F.Y. Liew, L. Romani
P384 - P404
Veterinary Immunology
Chair: B. Kaspers, A. Saalmüller
P405 - P418

Business Meetings
As per date of printing
Closed Business Meetings
Wednesday, September 3, 2008
10.00 – 12.00 hrs Steering Committee Meeting ECI 2009 Lecture Room 25 / Level 8
12.00 – 14.30 hrs Vorstandssitzung DGfI Hotel Regina – Salon Makart
Thursday, September 4, 2008
11.00 – 13.00 hrs Promotion Committee Meeting des ECI 2009 Lecture Room 25 / Level 8
12.30 – 14.00 hrs Sitzung der DGfI Kommission “Fachimmunologe” Lecture Room 13 / Level 7
Friday, September 5, 2008
12.00 – 14.00 hrs Arbeitskreise der DGfI Lecture Room 25 / Level 8
Saturday, September 6, 2008
09.00 – 11.00 hrs DGfI Educational Committee Lecture Room 25 / Level 8
26

Satellite Lunch Symposia
Thursday, September 4, 2008, 12.15 – 13.45 hrs, Lecture Hall 1
B cell: Promising target in autoimmune diseases
Chair: J. Smolen
The biology of the B cell in autoimmune diseases
A. Radbruch
Clinical experiences with B cell therapies
T. Dörner
Safety: Experiences with Rituximab
H-P. Brezinsek
Friday, September 5, 2008, 12.15 – 13.45 hrs, Lecture Hall 2
Immune modulation with intravenous immunoglobulin: the
established and the advances
Chair: S. Meuer
Introduction
S. Meuer
Immunthrombocytopenia as the first model for biological treatment with IVIG in chronic inflammatory and
autoimmune diseases
P. Imbach
Intravenous Immunoglobulins: mechanisms of action and options for improvement of therapeutic efficacy
F. Nimmerjahn
Basic research in human immunology creates new therapeutic options
S. Meuer
Discussion and wrap-up
Saturday, September 6, 2008, 10.30 – 12.45 hrs, Lecture Hall 1
Vom rekombinanten Allergen zu neuen Allergietherapien
Chairs: R. Valenta, N. Reider
Rekombinante Allergene: Vom Beginn zur Gegenwart
H. Breiteneder
Rekombinante Nahrungsmittelallergene
K. Hoffmann-Sommergruber
Klinische Anwendungen für rekombinante Allergene
P. Schmid-Grendelmeier
Klinische Erfahrungen mit Allergenchips
J.M. Baron
Die Komplexitaet von zellulaeren Allergietesten
J. Kleine-Tebbe
Immuntherapie und Verlaufkontrolle mit rekombinanten Allergenen
G. Pauli
12.45 - 13.00 Pause (mit Snack)
13.00 - 13.45 Klinische Fälle aus der Allergologie: „Wie hätten Sie entschieden”
27

Information on Posters
Poster Topics
P01 T-Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P001 – P056
P02 Innate Immunity: Antigen-Presenting Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P057 – P075
P03 Signal Transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P076 – P094
P04 Tumor Immunology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P095 – P117
P05 Innate Immunity: Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P118 – P134
P06 Pattern Recognition Receptors & Myeloid Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P135 – P151
P07 NK cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P152 – P164
P08 Vaccines & Adjuvants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P165 – P187
P09 Immunomodulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P188 – P208
P10 Alloimmunity & Tolerance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P209 – P233
P11 Allergy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P234 – P264
P12 Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P265 – P296
P13 Mucosal Immunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P297 – P308
P14 Autoimmunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P309 – P352
P15 B-Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P353 – P360
P16 Regulatory Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P361 – P383
P17 Cytokines, Chemokines & their receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P384 – P404
P18 Veterinary Immunology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P405 – P418
P19 Complement system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P420 – P420
Posters will be on display from Wednesday, September 3, (15.00 hrs) to Saturday, September 6, 2008,
(15.00 hrs).
Poster mounting will be possible on: Wednesday, September 3, 2008 from 10:00 - 15:00.
Removal will be possible on: Saturday, September 6, 2008 from 14:30 - 15:30.
Please note that posters not removed by then, will be taken down by conference staff and will not be
stored or forwarded to the authors after the meeting.
You will find your poster board number in the author index at the end of the abstract book.
Presence at Posters
In order to enable discussion and interaction with other participants, we request you or another member of your
group to be at your poster board at the following times:
Thursday, September 4, 2008, 09.30 – 10.30 hrs
T-Lymphocytes-1 P001 - P028
T-Lymphocytes-2 P029 - P056
Innate Immunity: Antigen-Presenting Cells P057 - P075
Signal Transduction P076 - P094
Tumor Immunology P095 - P117
Thursday, September 4, 2008, 15.30 – 16.30 hrs
Innate Immunity: Regulation P118 - P134
Pattern Recognition Receptors & Myeloid Cells P135 - P151
NK Cells P152 - P164
Vaccines & Adjuvants P165 - P187
Immunomodulation P188 - P208
Friday, September 5, 2008, 09.30 – 10.30 hrs
Alloimmunity & Tolerance P209 - P233
Allergy P234 - P264
Infection P265 - P296
Mucosal Immunity P297 - P308
Friday, September 5, 2008 15.30 – 16.30 hrs
Autoimmunity-1 P309 - P329
Autoimmunity-2 P330 - P352
B-Lymphocytes P353 - P360
Regulatory Lymphocytes P361 - P383
Cytokines, Chemokines & their receptors P384 - P404
Veterinary Immunology P405 - P418
Complement System P420
If this is not possible, please leave a note on your poster board detailing the times when you will be present at the board.
28

Information for Speakers
Projection and Technical Setting
All rooms will be equipped with data- and overhead projection (no slides).
It is essential that you load and view your presentation in the slide preview room preferably in the
morning of the day your talk is scheduled, but no later than 2 hours in advance.
The lecture rooms are exclusively equipped with Windows-PCs (no Macintosh machines). In case you
absolutely need to use your own laptop or notebook, please contact the preview center well in advance
of your talk.
Please bring a USB-stick or CD-ROM, all formatted for Windows® (PC). You may want to carry a second
disk/CD as a back-up in case there is any unsolvable technical problem.
File Format: Microsoft® Power Point presentation formatted for Windows® (PC) only. (Operating
system: Windows XP®)
Preferred Resolution: XGA (1024 x 768 pixel)
Preview Room
The Speaker’s Preview will be located in Room Nr. 11 on Level 7. Equipment for a final check of the sequence of your
presentation is available in the preview room. All presenters should bring their electronic presentation to the preview
room preferably in the morning of the day of the talk, but no later than 2 hours before the start of the session. For
sessions starting at 08.15 hrs, the PowerPoint presentations should be handed in the previous day.
Opening hours of the preview room:
Wednesday, September 3, 2008 12.00 – 18.00
Thursday, September 4, 2008 07.30 – 18.00
Friday, September 5, 2008 07.30 – 18.00
Saturday, September 6, 2008 08.15 – 15.00
Programme Changes
The organisers cannot assume any liability for changes in the programme due to external or unforeseen
circumstances.
29

Congress Information
Abstract Books
You will find an Abstract Book in your conference bag.
Accreditation
The Joint Annual Meeting of Immunology has applied for credits at the European Accreditation Council for Continuing
Medical Education, Institution of the UEMS.
The number of credits (which will be announced after the meeting) will figure on the respective confirmation,
which will also be sent after the meeting.
The rules of the EACCME state that participants are kindly asked to fill in the feedback (evaluation) form included
in the conference bag. It can be returned to the registration desk.
Participants applying for EACCME Credits will have to have their badge scanned daily at the registration
desk before entering the conference. The confirmation will be mailed after the conference at the end of
September.
Die österreichische Akademie der Ärzte hat an diese Veranstaltung 41 Diplomfortbildungspunkte
vergeben.
Admission to Lecture Halls
Participants are requested to enter the lecture halls via Level 8 only.
Badges
Participants will receive their name badges from the conference registration desk. Since only registered participants will be permitted
to attend scientific sessions, the exhibition and poster areas, you are kindly asked to wear your badge when entering the
congress venue. Please note that admission to scientific sessions is strictly restricted to participants wearing their badges. Exhibitors
and accompanying persons are not entitled to attend the scientific sessions. Lost badges can be replaced at the registration
desk. However, a handling fee of € 20,- will be charged.
The following badge-colours are used at the Congress:
White � Participants
Yellow � Accompanying Persons
Green � Exhibitors
Red � Staff
Cancellations and Refunds
Notice of cancellation must be made in writing by registered letter or fax to the Congress Office.
The policy for refunding registration fees is as follows:
Written cancellation received:
- before July 31, 2008: 75% refund
- after July 31, 2008: no refund
The date of the postmark or fax ID is the basis for considering refunds. Refunds will be made after the congress.
Cash Bar
Snacks and drinks may be purchased at the cash bar on Level 8 during congress hours.
Certificate of Attendance
Confirmations of attendance will be issued at the registration desk.
City Tour
The city tour “Classical Vienna – A City Stroll” will take place on Thursday, September 4, 2008. It is free of charge for accompanying
persons, however, registration in advance is mandatory.
Coffee Breaks
During the session breaks, refreshments will be served free of charge to participants wearing name badges.
Exhibition Opening Hours
Wednesday, September 3, 2008 15.00 – 17.00 hrs
Thursday, September 4, 2008 08.15 – 17.00 hrs
Friday, September 5, 2008 08.15 – 17.00 hrs
Saturday, September 6, 2008 08.45 – 15.00 hrs
Hotel and Tours Desk
Mondial, the official travel agency of the meeting, will be present at the conference on
Wednesday, September 3, 2008 from 14.30 – 17.30 hrs and on
Thursday, September 4, 2008 from 07.30 – 09.30 hrs.
If you have any questions regarding your hotel booking or the city tour, please approach Mondial. They will be located near the
registration desk.
Internet
A few internet stations will be available at the conference. Please ask at the registration desk. You may also find small internet
cafés throughout the city.
30

Congress Information
Message Board
A Message Board and notice of the daily programme are available on Level 7 and Level 8.
Poster Mounting and Removal
There are four poster sessions: Thursday and Friday from 09.30 – 10.30 hrs and from 15.30 – 16.30 hrs. Poster mounting will be
possible on Wednesday, September 3, 2008 from 10.00 – 15.00 hrs. Poster removal will be possible on Saturday, September 6,
2008 from 14.30 – 15.30 hrs. Please note that the organisers cannot assume any liability for loss or damage of posters displayed
in the poster area. Posters that are not removed by 15.30 hrs on Saturday, September 6, 2008 will be removed by staff and will
not be stored or forwarded to the author after the meeting.
Preview Room
The Speaker’s Preview will be located in Room Nr. 11 on Level 7. Equipment for a final check of the sequence of your presentation
is available in the preview room. All presenters should bring their electronic presentation to the preview room preferably in
the morning of the day of the talk, but not later than 2 hours before the start of the session. For sessions starting at 08.15 hrs,
the PowerPoint presentations should be handed in the previous day.
Following are the opening hours of the preview room:
Wednesday, September 3, 2008 12.00 – 18.00
Thursday, September 4, 2008 07.30 – 18.00
Friday, September 5, 2008 07.30 – 18.00
Saturday, September 6, 2008 08.15 – 15.00
Public Transport
Registered congress participants receive a 4-days-ticket when picking up their registration materials. This ticket is valid for all public
transport within Vienna from Wednesday, September 3, 2008 to Saturday, September 6, 2008. This ticket is not valid for going
to the airport, since the airport is out of town. Congress participants are kindly requested to return their ticket if it is not needed.
Registration Desk opening hours
Wednesday, September 3, 2008 10.00 – 18.00
Thursday, September 4, 2008 07.30 – 18.00
Friday, September 5, 2008 07.30 – 18.00
Saturday, September 6, 2008 08.15 – 15.00
Smoking Policy
The Joint Annual Meeting of Immunology is a “No-smoking-Conference”. Please note that smoking is banned from all public
buildings. Restaurants and bars may, depending on size, be declared either as “smoking” or “no-smoking” locations or have
separate areas and ventilation systems.
Staff
Should you have any questions, congress staff, recognizable by a blue t-shirt and red badge, will be pleased to help you.
31

Registration Fees
Onsite registration
Wednesday, September 3, 2008 10.00 – 18.00
Thursday, September 4, 2008 07.30 – 18.00
Friday, September 5, 2008 07.30 – 18.00
Saturday, September 6, 2008 08.15 – 15.00
Payment received before June 15, 2008 after June 15, 2008 and on-site
Members EUR 190.— EUR 300.—
Student Members* EUR 95.— EUR 135.—
Non-Members EUR 280.— EUR 390.—
Student Non-Members* EUR 140.— EUR 180.—
Accompanying Persons EUR 60.— EUR 60.—
Day Ticktet Member EUR 140,—
Day Ticket Non-Member EUR 180,—
* please provide a copy of an ID together with your registration
What is covered by the registration fee?
Participants Accompanying persons
Admission to all scientific sessions
Access to the exhibition
Coffee breaks
Welcome reception at the City Hall
Thursday, September 4, 2008, 19.00 hrs
Abstract book
Programme
4-days public transport ticket
Payment of registration fees may be made in cash (Euros only), by maestro debit card, or by the following credit cards:
Diners Club, Mastercard, Visa.
Please note that the reduced registration fee is only applicable if it has been credited to the congress account before the deadline.
Registering without performing an actual payment is not sufficient to benefit from the reduction. Pre-registration without
payment of the registration fee is possible. The full fee is to be paid at the registration desk.
Cancellations and refunds:
Notice of cancellation must be made in writing by registered letter or fax to the Congress Office.
Notice of cancellation must be made in writing by registered letter or fax to the Congress Office.
The policy for refunding registration fees is as follows:
Written cancellation received:
- before July 31, 2008: 75% refund
- after July 31, 2008: no refund
The date of the postmark or fax ID is the basis for considering refunds. Refunds will be made after the congress.
32
Admission to the welcome reception at the City Hall
Thursday, September 4, 2008, 19.00 hrs
Classical Vienna City Tour*,
Thursday, September 4, 2008, 09.00 hrs
Access to the exhibition and coffee breaks
(no admission to lectures)
*Please note that the classical city tour is not available for
on site registrations of accompanying persons.

General Information
Bank services - Money matters
Banks are open from 8.30 – 12:30 and from 13:30 – 15:00, Monday to Friday. Some banks are also open on Thursday afternoons
until 17:30 hrs. Cash machines (ATMs), which accept all major international bank cards, are available throughout the city. There
is a cash machine in the main entrance of the Vienna General Hospital. The currency of Austria is the Euro (€). Major credit cards
are widely accepted, but please always check beforehand.
Car Parking
The Vienna General Hospital has approximately 800 car parking spaces available for visitors in an underground car park. The
entrance is at Währinger Gürtel.
Eating out in Vienna
Vienna has a broad variety of local and international restaurants, many of them located in the old city and in the vicinity of the conference
venue.
Emergency services
The phone number to dial for emergencies is 112.
GSM cell phone roaming
GSM cell/mobile phone roaming is available without any problems for all major international providers. It is advisable to inquire
beforehand at your provider which roaming company in Austria offers the cheapest tariffs.
Insurance
In registering for the Joint Annual Meeting of Immunology 2008 participants agree that neither the organising committee nor
the congress office assume any liability whatsoever. Participants are requested to make their own arrangements for health and
travel insurance.
Internet and printing facilities
A few internet stations will be available at the conference. Please ask at the registration desk. You may also find small internet
cafés throughout the city.
Language
The official language of the congress will be English (no simultaneous translation).
Medical care
The Austrian National Health Service may be used by all persons from European Union countries who have the E111 Form (EHI-
Card). This form/card should be obtained at the health service or post office of the visitor’s home country before travelling to
Austria. It is advisable for participants from countries outside the European Union to take out medical insurance before reaching
Austria, since they will be charged for access to the national health system.
Pharmacies
Medicines that do not require a medical prescription may be purchased over the counter. If you need advice, do not hesitate to
ask the pharmacist. If you usually take medication, it is advisable to bring a sufficient amount with you for your trip. Pharmacies
in the vicinity of the conference venue are on Zimmermannplatz 1, 1090 Vienna. There are duty pharmacies open 24 hours a day.
Outside each pharmacy there is a list of the nearest duty pharmacies, or you may ask at your hotel reception for more information.
Safety - Crime
Visitor safety is generally adequate. Like in any other major European city, you can walk everywhere using common sense. Pick
pocketing in heavily visited tourist zones or in public transport lines might be a concern.
Unfortunately experience has shown that some basic precautionary measures should always be kept in mind in any city:
- Do not carry important items like flight tickets, passports etc. with you when visiting the conference or strolling through the city;
leave them in the hotel safe during your stay. Rather carry a photocopy of your passport or an identity card with you.
- Try not to carry all documents, money, credit cards and other essential items and valuables in one bag. If it gets lost or stolen,
everything will be gone and might be difficult to replace on short notice, especially passports and visa to return to your country
of residence.
- Take off your name badge when leaving the conference centre.
Shops
Shops in Vienna are generally open between 09.00 and 18.00 hrs Mon-Fri, and between 09.00 and 12.00 on Saturdays. Some
shops are open until 19.00 Mon-Fri and until 17.00 on Saturdays. Shops are usually closed on Sundays, except for a few establishments
with special permits.
Taxis
There are Taxi ranks throughout the city, but calling is often your best option. Please address your hotel reception or the registration
desk of the conference venue. A taxi station can be found in front of the main entrance at Level 5 and at Lazarettgasse
(exit on Level 4).
Tipping
Tips are not obligatory in Austria, although people usually tip approximately 10% at restaurants, cafés and bars. Hotel and airport
porters will accept tips, depending on the luggage.
33

General Information
Travelling within Vienna
Registered congress participants receive a 4-days-ticket when picking up their registration materials. This ticket is valid for all public
transport within Vienna from Wednesday, September 3, 2008 to Saturday, September 6, 2008. This ticket is not valid for going
to the airport, since it is out of town. Congress participants are kindly requested to return their ticket if it is not needed.
For accompanying persons and exhibitors tickets are available from machines at underground stations (maestro debit cards accepted),
at news agents’, or at Vienna Transport Authority’s ticket offices. Tickets bought in advance are cheaper and must be
punched in a blue ticket cancelling machine on the tram or bus, or at the barrier before boarding the underground train.
Single trip tickets can be used for any single trip within Vienna. You may change lines (and switch between bus, tram, underground,
or urban train), but you may not interrupt your journey. Ticket price: EUR 1.70 when bought in advance; EUR 2.20 when
bought in the means of transport.
The 24-hour pass is valid throughout Vienna for exactly 24 hours from the time it is punched. Price: EUR 5.70
The 72-hour pass is valid throughout Vienna for exactly 72 hours from the time it is punched. Price: EUR 13.60
The 8-day ticket is valid for any eight days, not necessarily eight consecutive days. It is a rover ticket, which means you can travel
all around Vienna. You can also use the ticket for several people travelling together. Simply punch one strip for each person in the
group. Price: EUR 27.20
Week-pass valid from Monday to Monday, 09.00 hrs. Price: EUR 14.00
A taxi is the most comfortable way of getting around the city but also the most expensive. They are identifiable by their roof-sign
which is lit when available. Prices must be displayed inside the cab and meters (which are compulsory in all cabs) will indicate
the fare.
Travelling from and to the Airport
Vienna International Airport is located 13 kilometres south east of Vienna.
City Airport Train (CAT)
The train service between the airport and the city centre (City Air Terminal – Station ‘Wien Mitte’) is every 30 minutes and takes
16 minutes. It is covered from 6:05 hrs to 00:05 hrs (Airport to City) and from 5:38 hrs to 23:38 hrs (City to Airport). Tickets may
be purchased online (EUR 8.00 single or EUR 15.00 return), from ticket machines at the airport/station (EUR 9.00 single or EUR
16.00 return) or on board (EUR 10.00 single). From ‘Wien Mitte’ you can take the green line (U4) direction Heiligenstadt and get
off at ‘Spittelau’ (five stops) and then take the brown line (U6) direction Siebenhirten and get off at Michelbeuern-Allgemeines
Krankenhaus.
Taxi fares to the conference venue are about EUR 35.00 and take around 25 minutes. There is a taxi rank outside the airport terminal.
Night-time fees are slightly higher.
Travelling to the Vienna General Hospital by Public Transportation
The Vienna General Hospital (the congress venue) is easily reachable by taking the subway line U6 (the brown line) and getting
off at Michelbeuern – Allgemeines Krankenhaus. Furthermore, it can be reached by tramway 42, tramways 5 and 33 (stop
Lazarettgasse) as well as tramways 43 and 44 (stop Alser Straße).
Vienna
Vienna, the capital of Austria, 2 million inhabitants, is situated on the banks of the Danube. Vienna is a dream city for anyone with
an interest in history. Narrow, medieval alleyways and grand boulevards lead to historic sights such as the Imperial Palace (Hofburg),
Belvedere Palace, Burgtheater, the Spanish Riding School, St. Stephen’s Cathedral, the Opera House, Karlskirche, or
Schönbrunn Palace. Vienna has been synonymous with music for centuries, and was home to Mozart, Beethoven, Schubert and
Johann Strauss. The Vienna Philharmonic Orchestra is one of the world’s top orchestras; the Vienna Boys’ Choir is triumphantly
successful wherever it tours. Vienna possesses a lively and vast array of cultural attractions, from classical or experimental theatre,
film or dance festivals, opera or operetta, to exhibitions and concerts. The Museum of Fine Arts is one of the world’s largest
and most distinguished museums, housing priceless works of art. Art accompanies you wherever you go in Vienna - even some
of its underground stations are listed properties on account of their elegant, ornamental Jugendstil (Art Nouveau) style designed
by Otto Wagner. For more information about Vienna, please see www.aboutvienna.org.
34

Venue
Location of the Vienna General Hospital and the Lecture Centre
GENERAL INFORMATION
Congress venue
Vienna General Hospital
Allgemeines Krankenhaus Wien
Lecture Hall Centre
Hörsaalzentrum
Währinger Gürtel 18-20
A-1090 Vienna, Austria
HÖRSAALZENTRUM
EBENE 07/08
Public transportation in Vienna
The Vienna General Hospital (the congress venue) is easily reachable by taking the subway line U6 and getting off
at the station ”Michelbeuern – Allgemeines Krankenhaus”. Furthermore it can be reached with the tramway 42, the
tramway 5 and 33 (station ”Lazarettgasse”) as well as the tramways 43 and 44 (station ”Alser Strasse”)
35

Venue 36
Level 7
Access from main entrance
No entrance to Lecture Halls.
Please use the doors on Level 8.
Meeting
Room 13
Level 8
Access to Lecture Halls
? Entrance to Lecture Halls
Escalators to main entrance
Green Elevators to main entrance
Lecture
Hall 2
?? ? ? ? ?
Lecture
Hall 1
Lecture
Hall 3
? ? ? ? ? ?
Coffee
Escalators to main entrance
Green Elevators to main entrance
Lecture
Hall 2
Exhibition
Registration
Red Elevators
Lecture
Hall 5
Lecture
Hall 4
Coffee
e
e
f
f
o
C
n
o
i
t
i
b
i
h
x
E
?? ? ? ? ?
Lecture
Hall 1
Lecture
Hall 3
? ? ? ? ? ?
Posters and Exhibition
Coffee
Red Elevators
Lecture
Hall 5
Lecture
Hall 4
Posters
? ? ? ?
s
r
e
t
s
o
P
r
a
B
h
s
a
C
n
o
i
t
i
b
i
h
x
E
Cloakroom
Posters
Preview
Room
Posters
Meeting
Room
25
Posters

Social Events
Thursday, September 4, 2008, 19.00 hrs
Welcome Reception by the Mayor of Vienna at the Vienna City Hall
The mayor of the city of Vienna is pleased to invite you to a Welcome Reception. Meet your colleagues at this event. Enjoy the
evening with a Buffet and live music.
Dress code: business attire
Attendance is free for registered participants and accompanying persons. Those who have registered prior to the congress
should have received their ticket with the congress material. Please remember to bring your ticket.
Please note that attendance is limited and advance registration is mandatory in order to receive a ticket!
A limited number of tickets will still be available for onsite bookings.
Venue: Vienna City Hall, Lichtenfelsgasse 2, 1010 Vienna
Directions: From the conference venue take the brown underground line U6 (direction Siebenhirten) one stop and get off at Alser
Strasse. Take the tram 43 (direction Schottentor) and get off at Landesgerichtsstrasse. From there you can walk along Landesgerichtsstrasse
until you reach the city hall on your left hand side. Walk past the city hall and turn left into Lichtenfelsgasse. The
entrance to the reception is on your left.
Alternatively you can take the brown underground line U6 (direction ‘Floridsdorf’) three stops and get off at ‘Spittelau’. Take the
green underground line U4 (direction ‘Hütteldorf’) three stops and get off at ‘Schottenring’. Take the purple underground line U2
(direction ‘Karlsplatz’) two stops and get off at ‘Rathaus’. Take the exit towards the front of the train and turn left and cross the
street. This is Lichtenfelsgasse. The entrance to the Reception is on the left hand side.
Friday, September 5, 2008, 19.30 hrs.
Dinner at a Viennese “Heuriger”
An evening spent in typical Austrian wine taverns in Vienna. You will be served a delicious Austrian buffet and excellent local
wines while enjoying the atmosphere of a traditionally decorated restaurant. “Heuriger” could be translated with “of this year”
and means a young crisp wine produced during the current wine season. Only wine producers serving their own product,
grown in the vineyards of Vienna, may call their tavern “Heuriger”.
Dress code: casual
Venue: Weingut Fuhrgassl Huber
Neustift/Walde 68
1190 Vienna
Buses depart from the main entrance on Level 5 of the Vienna General Hospital, at 19.30 hrs and return in the late
evening.
Price per ticket including transport, music, food and beverages: EUR 45.–
Please note that advance registration is mandatory in order to receive a ticket! A limited number of tickets will still be
available for onsite bookings.
37

Underground Map 38
9
Congress
venue
Welcome
Reception

City Map 39
��
����������������������
�����������������������
�
�
1) Lecture Centre of the Vienna
General Hospital (AKH)
2) City Hall (Welcome Reception)
3) Arcotel Boltzmann
4) Mercure Josefshof
5) Hotel & Palais Strudlhof
6) Carlton Opera
�
�
�
�
�
��
��
�
7) Wandl
8) Atlas
9) Academia
10) Pension Ani Falstaff
11) Pension Ani
12) Regina
13) Royal
�
��

Exhibition – General Information
Exhibiton Organiser:
Name MAW – Medizinische Ausstellungs- und Werbegesellschaft
Address Freyung 6
1010 Vienna, Austria
Telephone Ms. Ingrid Winkler: +43 664 441 8285
Ms. May-Britt Ernst: +43 664 105 2018
Fax +43 1 535 6016
E-mail maw@media.co.at
Exhibition Dates & Opening hours:
Wednesday, September 3, 2008 15.00 – 17.00 hrs
Thursday, September 4, 2008 08.15 – 17.00 hrs
Friday, September 5, 2008 08.15 – 17.00 hrs
Saturday, September 6, 2008 08.45 – 15.00 hrs
Poster Mounting, Poster Viewing, Poster Removal Hours
Wednesday, September 3, 2008 – poster mounting 10.00 – 15.00 hrs
Wednesday, September 3, 2008 – poster viewing 15.00 – 18.00 hrs
Thursday, September 4, 2008 – poster viewing 08.15 – 18.00 hrs
Friday, September 5, 2008 – poster viewing 08.15 – 18.00 hrs
Saturday, September 6, 2008 – poster viewing 08.45 – 14.30 hrs
Saturday, September 6, 2008 – poster removal 14.30 – 15.30 hrs
Location
Venue Lecture Centre of the Vienna General Hospital
Exhibition Areas Level 7 and Level 8
Address Währinger Gürtel 18-20, 1090 Vienna, Austria
40

List of Sponsors, Exhibitors and Advertisers*
Ärztezentrale Adressen- und Drucksortenverlag, Vienna, Austria
Abd Serotec- Endeavour House, Oxon, United Kingdom
Acris Antibodies, Hiddenhausen, Germany
Active Motif Europe, Rixensart, Belgium
Aesca Pharma, Traiskirchen, Austria
Alk Abello Allergie – Service GmbH, Linz, Austria
Allergopharma, Vienna, Austria
AstraZeneca Österreich, Vienna, Austria
Becton Dickinson Austria, Schwechat, Austria
Bencard Allergie, Vienna, Austria
Bender Medsystems, Vienna, Austria
Biomedica, Vienna, Austria
Bio-Rad Laboratories, Munich, Germany
Biotest AG, Dreieich, Germany
Biozym Biotech Trading, Vienna, Austria
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
CellGenix Technologie Transfer, Freiburg, Germany
Cell Kinetice, Lod, Israel
2 nd European Congress of Immunology – ECI 2009
eubio, Vienna, Austria
Fermentas, St. Leon-Rot, Germany
GE Healthcare Europe, Vienna, Austria
Greiner Bio – One, Kremsmünster, Austria
Hal Allergy, Vienna, Austria
41
*(as per printing date)

List of Sponsors, Exhibitors and Advertisers*
Invitrogen, Karlsruhe, Germany
Jackson ImmunoResearch Europe Ltd., Suffolk, United Kingdom
LaVision BioTec, Bielefeld, Germany
Mabtech AB, Nacka Strand, Sweden
Ferdinand Menzl Medizintechnik, Vienna, Austria
Miltenyi Biotec, Bergisch Gladbach, Germany
NatuTec, Frankfurt am Main, Germany
New England Biolabs, Frankfurt am Main, Germany
Novartis Pharma, Vienna, Austria
Octapharma, Lachen, Switzerland
Partec, Görlitz, Germany
PeproTech, Hamburg, Germany
Phadia Austria, Vienna, Austria
Porsche Austria
ProFas, Regensburg, Germany
Charles River Consulting, Sulzfeld, Germany
Roche Austria, Vienna, Austria
R + D Systems, Wiesbaden, Germany
Siemens Medical Solutions Diagnostics, Vienna, Austria
Stallergenes France, Antony Cedex, France
Stemcell Technologies, Grenoble, France
tebu – bio, Offenbach, Germany
THP Medical Products, Vienna, Austria
Werfen Austria, Vienna, Austria
Wiley Blackwell, Weinheim, Germany
Yakult Deutschland, Neuss Germany
42
*(as per printing date)

Notes
Printed in Austria by: ROBIDRUCK, 1200 Vienna – www.robidruck.co.at

Das Immunglobulin in
seiner natürlichen Form
Natur
weitergeben
Zusammensetzung: 1 ml Intratect® enthält 50 mg Plasmaproteine vom Menschen, davon mind. 96 % IgG (57,2 % IgG1, 37,2 % IgG2, 3,1 % IgG3, 3,0 % IgG4). Höchstgehalt an IgA: 2 mg/ml. Hilfsstoffe: Glycin, Wasser zur
Injektion. Anwendungsgebiete: Substitutionstherapie bei primären Immunmangelsyndromen, sekundärer Hypogammaglobulinämie und rezidivierenden bakteriellen Infektionen bei CLL und multiplem Myelom,
Kinder mit angeborenem AIDS und rezidivierenden Infektionen. Immunmodulation bei ITP bei Kindern oder Erwachsenen mit einem hohen Blutungsrisiko oder vor chirurgischen Eingriffen zur Korrektur der
Thrombozytenzahl, Guillain-Barré-Syndrom und Kawasaki-Syndrom. Allogene Knochenmarktransplantation. Art der Anwendung, Dosierung: Intratect® wird intravenös verabreicht. Dosierung und Intervalle der
Infusionen richten sich nach der Indikation. Gegenanzeigen: Überempfi ndlichkeit gegen jegliche Bestandteile des Präparates. Überempfi ndlichkeit gegen homologe Immunglobuline, insbesondere in den sehr
seltenen Fällen von IgA-Mangel, wenn der Patient Antikörper gegen IgA aufweist. Spezielle Hinweise: Bestimmte schwere unerwünschte Nebenwirkungen können im Zusammenhang mit der Infusionsgeschwindigkeit
stehen. Es ist die in der Gebrauchsinformation beschriebene Infusionsgeschwindigkeit zu beachten. Die Patienten müssen während der gesamten Dauer der Infusion kontrolliert und auf Symptome unerwünschter
Wirkungen beobachtet werden. Bestimmte unerwünschte Nebenwirkungen können bei einer hohen Infusionsgeschwindigkeit häufi ger auftreten, bei Patienten mit Hypo- oder Agammaglobulinämie
mit oder ohne IgA-Mangel, bei Patienten, die zum ersten Mal Immunglobulin vom Menschen erhalten oder, in seltenen Fällen, bei einem Wechsel des Immunglobulin-Präparates oder nach einer längeren Behandlungspause.
Nebenwirkungen: Gelegentlich können Schüttelfrost, Kopfschmerzen, Fieber, Übelkeit und Erbrechen, allergische Reaktionen, niedriger Blutdruck, Gelenkschmerzen und leichte Rückenschmerzen.
Selten: plötzlicher Blutdruckabfall, vorrübergehende Hautreaktionen, Anstieg des Serumkreatinin-Spiegels, akutes Nierenversagen, thromboembolische Komplikationen. In Einzelfällen: anaphylaktischer Schock,
reversible aseptische Meningitis, reversible hämolytische Anämie/Hämolyse. Wechselwirkungen: Die Gabe von Immunglobulin kann für eine Dauer von mindestens 6 Wochen und bis zu 3 Monaten die Wirksamkeit
von attenuierten Lebendimpfstoffen wie Masern-, Röteln-, Mumps- und Windpockenimpfstoffen beeinträchtigen. Nach der Gabe dieses Präparates ist vor der Impfung mit attenuierten Lebendimpfstoffen
eine Wartezeit von 3 Monaten einzuhalten. Bei Masernimpfung kann diese Beeinträchtigung bis zu einem Jahr fortbestehen. Daher sollte bei Patienten, die Masernimpfstoff erhalten, der Antikörperstatus überprüft
werden. Handelsformen: Gebrauchsfertige Lösung zur intravenösen Infusion in Durchstichfl aschen aus Glas zu 20 ml (1,0 g), 50 ml (2,5 g), 100 ml (5,0 g) und 200 ml (10,0 g).
Biotest Pharma GmbH · Postfach 10 20 40 · D-63266 Dreieich · www.biotest.de
Intratect_DGN.260706.indd 1 01.08.2006 11:41:20 Uhr